Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000518.5(HBB):c.441C>G (p.His147Gln)	HBB|LOC107133510|LOC110006319	H147Q	HEMOGLOBIN KODAIRA II	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015601	11	5246831	11	5225601	15601	30640	rs33985739	NC_000011.10:5225600:G:C
NM_000518.5(HBB):c.441C>A (p.His147Gln)	HBB|LOC107133510|LOC110006319	H147Q	HEMOGLOBIN KODAIRA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015498	11	5246831	11	5225601	15498	30537	rs33985739	NC_000011.10:5225600:G:T
NM_000518.4(HBB):c.440A>C (p.His147Pro)	HBB|LOC107133510|LOC110006319	H147P	Erythrocytosis, familial, 6|HEMOGLOBIN YORK	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015395	11	5246832	11	5225602	15395	30434	rs33954264	NC_000011.10:5225601:T:G
NM_000518.4(HBB):c.440A>T (p.His147Leu)	HBB|LOC107133510|LOC110006319	H147L	Erythrocytosis, familial, 6|HEMOGLOBIN COWTOWN	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015144	11	5246832	11	5225602	15144	30183	rs33954264	NC_000011.10:5225601:T:A
NM_000518.4(HBB):c.440A>G (p.His147Arg)	HBB|LOC107133510|LOC110006319	H147R	HEMOGLOBIN COCHIN-PORT ROYAL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015139	11	5246832	11	5225602	15139	30178	rs33954264	NC_000011.10:5225601:T:C
NM_000518.4(HBB):c.439C>T (p.His147Tyr)	HBB|LOC107133510|LOC110006319	H147Y	HEMOGLOBIN BOLOGNA-ST. ORSOLA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015577	11	5246833	11	5225603	15577	30616	rs33961444	NC_000011.10:5225602:G:A
NM_000518.4(HBB):c.439C>G (p.His147Asp)	HBB|LOC107133510|LOC110006319	H147D	HEMOGLOBIN HIROSHIMA|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015200	11	5246833	11	5225603	15200	30239	rs33961444	NC_000011.10:5225602:G:C
NM_000518.5(HBB):c.437A>G (p.Tyr146Cys)	HBB|LOC107133510|LOC110006319	Y146C	not provided	Pathogenic(Last reviewed: Apr 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015322	11	5246835	11	5225605	15322	30361	rs35117167	NC_000011.10:5225604:T:C
NM_000518.5(HBB):c.436T>A (p.Tyr146Asn)	HBB|LOC107133510|LOC110006319	Y146N	Hemoglobinopathy	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000633256	11	5246836	11	5225606	633256	621358	rs33949869	NC_000011.10:5225605:A:T
NM_000518.5(HBB):c.436T>C (p.Tyr146His)	HBB|LOC107133510|LOC110006319	Y146H	not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000015112	11	5246836	11	5225606	15112	30151	rs33949869	NC_000011.10:5225605:A:G
NM_000518.5(HBB):c.435G>T (p.Lys145Asn)	LOC107133510|LOC110006319|HBB	K145N	not provided	not provided	no assertion provided	VCV000156328	11	5246837	11	5225607	156328	166108	rs35020585	NC_000011.10:5225606:C:A
NM_000518.5(HBB):c.435G>C (p.Lys145Asn)	HBB|LOC107133510|LOC110006319	K145N	not provided	Pathogenic(Last reviewed: Oct 6, 2021)	criteria provided, single submitter	VCV000015096	11	5246837	11	5225607	15096	30135	rs35020585	NC_000011.10:5225606:C:G
NM_000518.5(HBB):c.434A>T (p.Lys145Met)	HBB|LOC107133510|LOC110006319	K145M	HEMOGLOBIN BARBIZON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015576	11	5246838	11	5225608	15576	30615	rs33996892	NC_000011.10:5225607:T:A
NM_000518.4(HBB):c.[424C>G;433A>T]	HBB|LOC107133510|LOC110006319	K145*, L142V	HEMOGLOBIN KOCHI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446749	11|11	5246839	11|11	5225609	446749	38409|30656	rs33964352|rs33970699	NC_000011.10:5225608:T:A|NC_000011.10:5225617:G:C
NM_000518.4(HBB):c.433A>G (p.Lys145Glu)	HBB|LOC107133510|LOC110006319	K145E	HEMOGLOBIN MITO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015268	11	5246839	11	5225609	15268	30307	rs33964352	NC_000011.10:5225608:T:C
Hb Little Rock	HBB|LOC107133510|LOC110006319	H144Q	Erythrocytosis, familial, 6	Pathogenic(Last reviewed: Jan 1, 1987)	no assertion criteria provided	VCV000015250	11	5246840	11	5225610	15250	30289	rs36020563	NC_000011.10:5225609:G:Y
NM_000518.5(HBB):c.431A>C (p.His144Pro)	HBB|LOC107133510|LOC110006319	H144P	not specified	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000015365	11	5246841	11	5225611	15365	30404	rs33918338	NC_000011.10:5225610:T:G
NM_000518.5(HBB):c.431A>G (p.His144Arg)	HBB|LOC107133510|LOC110006319	H144R	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015090	11	5246841	11	5225611	15090	30129	rs33918338	NC_000011.10:5225610:T:C
NM_000518.4(HBB):c.430C>T (p.His144Tyr)	HBB|LOC107133510|LOC110006319	H144Y	not specified|not provided	Likely benign(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015565	11	5246842	11	5225612	15565	30604	rs33929415	NC_000011.10:5225611:G:A
NM_000518.4(HBB):c.430C>G (p.His144Asp)	HBB|LOC107133510|LOC110006319	H144D	HEMOGLOBIN RANCHO MIRAGE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015503	11	5246842	11	5225612	15503	30542	rs33929415	NC_000011.10:5225611:G:C
NM_000518.5(HBB):c.428C>T (p.Ala143Val)	HBB|LOC107133510|LOC110006319	A143V		no interpretation for the single variant	no interpretation for the single variant	VCV000478854	11	5246844	11	5225614	478854	38472	rs33921821	NC_000011.10:5225613:G:A
NM_000518.4(HBB):c.428C>A (p.Ala143Asp)	HBB|LOC107133510|LOC110006319	A143D	Erythrocytosis, familial, 6|HEMOGLOBIN OHIO	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015294	11	5246844	11	5225614	15294	30333	rs33921821	NC_000011.10:5225613:G:T
NM_000518.5(HBB):c.427G>A (p.Ala143Thr)	LOC110006319|HBB|LOC107133510	A143T	not provided	Uncertain significance(Last reviewed: Nov 18, 2018)	criteria provided, single submitter	VCV000801193	11	5246845	11	5225615	801193	789495	rs33931806	NC_000011.10:5225614:C:T
NM_000518.5(HBB):c.427G>C (p.Ala143Pro)	HBB|LOC107133510|LOC110006319	A143P	HEMOGLOBIN TOYOAKE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015376	11	5246845	11	5225615	15376	30415	rs33931806	NC_000011.10:5225614:C:G
NM_000518.5(HBB):c.425T>G (p.Leu142Arg)	HBB|LOC107133510|LOC110006319	L142R	HEMOGLOBIN OLMSTED	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015298	11	5246847	11	5225617	15298	30337	rs35854892	NC_000011.10:5225616:A:C
NM_000518.5(HBB):c.424C>G (p.Leu142Val)	HBB|LOC107133510|LOC110006319	L142V		no interpretation for the single variant	no interpretation for the single variant	VCV000478888	11	5246848	11	5225618	478888	30656	rs33970699	NC_000011.10:5225617:G:C
NM_000518.4(HBB):c.422C>T (p.Ala141Val)	HBB|LOC107133510|LOC110006319	A141V	HEMOGLOBIN PUTTELANGE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015545	11	5246850	11	5225620	15545	30584	rs33927093	NC_000011.10:5225619:G:A
NM_000518.4(HBB):c.422C>A (p.Ala141Asp)	LOC107133510|HBB|LOC110006319	A141D	not specified	Uncertain significance(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000015197	11	5246850	11	5225620	15197	30236	rs33927093	NC_000011.10:5225619:G:T
NM_000518.5(HBB):c.421G>A (p.Ala141Thr)	HBB|LOC107133510|LOC110006319	A141T	HEMOGLOBIN SAINT JACQUES|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015339	11	5246851	11	5225621	15339	30378	rs34980264	NC_000011.10:5225620:C:T
NM_000518.5(HBB):c.420T>A (p.Asn140Lys)	HBB|LOC107133510|LOC110006319	N140K	HEMOGLOBIN HINSDALE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015198	11	5246852	11	5225622	15198	30237	rs34240441	NC_000011.10:5225621:A:T
NM_000518.5(HBB):c.419A>C (p.Asn140Thr)	HBB|LOC107133510|LOC110006319	N140T	HEMOGLOBIN SAGAMI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015573	11	5246853	11	5225623	15573	30612	rs34407387	NC_000011.10:5225622:T:G
NM_000518.4(HBB):c.418A>T (p.Asn140Tyr)	HBB|LOC107133510|LOC110006319	N140Y	HEMOGLOBIN AURORA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015547	11	5246854	11	5225624	15547	30586	rs33910475	NC_000011.10:5225623:T:A
NM_000518.4(HBB):c.418A>G (p.Asn140Asp)	HBB|LOC107133510|LOC110006319	N140D	HEMOGLOBIN GEELONG|HEMOGLOBIN JINAN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015182	11	5246854	11	5225624	15182	30221	rs33910475	NC_000011.10:5225623:T:C
NM_000518.4(HBB):c.415G>A (p.Ala139Thr)	HBB|LOC107133510|LOC110006319	A139T	HEMOGLOBIN BUZEN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015606	11	5246857	11	5225627	15606	30645	rs33919821	NC_000011.10:5225626:C:T
NM_000518.4(HBB):c.415G>C (p.Ala139Pro)	HBB|LOC107133510|LOC110006319	A139P	HEMOGLOBIN BROCKTON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015119	11	5246857	11	5225627	15119	30158	rs33919821	NC_000011.10:5225626:C:G
NM_000518.4(HBB):c.410G>A (p.Gly137Asp)	HBB|LOC107133510|LOC110006319	G137D	Inborn genetic diseases|Beta-thalassemia HBB/LCRB|not specified|not provided|beta Thalassemia|Hb SS disease	Conflicting interpretations of pathogenicity(Last reviewed: Aug 26, 2022)	criteria provided, conflicting interpretations	VCV000015202	11	5246862	11	5225632	15202	30241	rs33949486	NC_000011.10:5225631:C:T
NM_000518.5(HBB):c.409G>C (p.Gly137Arg)	HBB|LOC107133510|LOC110006319	G137R	HEMOGLOBIN 'T LANGE LAND	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015590	11	5246863	11	5225633	15590	30629	rs33984863	NC_000011.10:5225632:C:G
NM_000518.5(HBB):c.407C>A (p.Ala136Asp)	HBB|LOC107133510|LOC110006319	A136D	HEMOGLOBIN BECKMAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015531	11	5246865	11	5225635	15531	30570	rs35669628	NC_000011.10:5225634:G:T
NM_000518.5(HBB):c.406G>C (p.Ala136Pro)	LOC107133510|LOC110006319|HBB	A136P	HEMOGLOBIN ALTDORF	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015095	11	5246866	11	5225636	15095	30134	rs35492035	NC_000011.10:5225635:C:G
NM_000518.4(HBB):c.404T>C (p.Val135Ala)	HBB|LOC107133510|LOC110006319	V135A	not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 15, 2022)	criteria provided, conflicting interpretations	VCV000015588	11	5246868	11	5225638	15588	30627	rs33966761	NC_000011.10:5225637:A:G
NM_000518.5(HBB):c.404T>A (p.Val135Glu)	HBB|LOC107133510|LOC110006319	V135E	Hemoglobinopathy	Pathogenic(Last reviewed: Jan 1, 1987)	no assertion criteria provided	VCV000015290	11	5246868	11	5225638	15290	30329	rs33966761	NC_000011.10:5225637:A:T
NM_000518.5(HBB):c.401T>C (p.Val134Ala)	HBB|LOC107133510|LOC110006319	V134A	HEMOGLOBIN RENERT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015585	11	5246871	11	5225641	15585	30624	rs35825479	NC_000011.10:5225640:A:G
NM_000518.5(HBB):c.400G>C (p.Val134Leu)	HBB|LOC107133510|LOC110006319	V134L	HEMOGLOBIN EXTREMADURA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015164	11	5246872	11	5225642	15164	30203	rs34095019	NC_000011.10:5225641:C:G
NM_000518.5(HBB):c.399A>T (p.Lys133Asn)	HBB|LOC107133510|LOC110006319	K133N	not specified	Uncertain significance(Last reviewed: Jan 27, 2021)	criteria provided, single submitter	VCV001330067	11	5246873	11	5225643	1330067	1320750		NC_000011.10:5225642:T:A
NM_000518.5(HBB):c.399A>Y (p.Lys133Asn)	HBB|LOC107133510|LOC110006319	K133N	HEMOGLOBIN YAMAGATA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015392	11	5246873	11	5225643	15392	30431	rs33946775	NC_000011.10:5225642:T:R
NM_000518.5(HBB):c.397A>C (p.Lys133Gln)	HBB|LOC107133510|LOC110006319	K133Q	not specified|not provided	Likely benign(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015233	11	5246875	11	5225645	15233	30272	rs33953406	NC_000011.10:5225644:T:G
NM_000518.5(HBB):c.396G>C (p.Gln132His)	HBB|LOC107133510|LOC110006319	Q132H	HEMOGLOBIN SILVER SPRINGS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015564	11	5246876	11	5225646	15564	30603	rs34188626	NC_000011.10:5225645:C:G
NM_000518.4(HBB):c.395A>G (p.Gln132Arg)	HBB|LOC107133510|LOC110006319	Q132R	HEMOGLOBIN SARREBOURG	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015523	11	5246877	11	5225647	15523	30562	rs33950778	NC_000011.10:5225646:T:C
NM_000518.4(HBB):c.395A>C (p.Gln132Pro)	HBB|LOC107133510|LOC110006319	Q132P	HEMOGLOBIN SHANGHAI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015348	11	5246877	11	5225647	15348	30387	rs33950778	NC_000011.10:5225646:T:G
NM_000518.5(HBB):c.394C>G (p.Gln132Glu)	HBB|LOC107133510|LOC110006319	Q132E	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 9, 2021)	criteria provided, conflicting interpretations	VCV000439160	11	5246878	11	5225648	439160	432671	rs33910209	NC_000011.10:5225647:G:C
NM_000518.5(HBB):c.394C>A (p.Gln132Lys)	LOC110006319|HBB|LOC107133510	Q132K	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2018)	criteria provided, conflicting interpretations	VCV000015349	11	5246878	11	5225648	15349	30388	rs33910209	NC_000011.10:5225647:G:T
NM_000518.5(HBB):c.392A>C (p.Tyr131Ser)	HBB|LOC107133510|LOC110006319	Y131S	HEMOGLOBIN NEVERS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015284	11	5246880	11	5225650	15284	30323	rs33937535	NC_000011.10:5225649:T:G
NM_000518.5(HBB):c.391T>G (p.Tyr131Asp)	HBB|LOC107133510|LOC110006319	Y131D	HEMOGLOBIN WIEN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015388	11	5246881	11	5225651	15388	30427	rs35834416	NC_000011.10:5225650:A:C
NM_000518.5(HBB):c.389C>T (p.Ala130Val)	HBB|LOC107133510|LOC110006319	A130V	Hemoglobinopathy|not provided|Hb SS disease	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2022)	criteria provided, conflicting interpretations	VCV000015245	11	5246883	11	5225653	15245	30284	rs111645889	NC_000011.10:5225652:G:A
NM_000518.5(HBB):c.389C>A (p.Ala130Asp)	HBB|LOC107133510|LOC110006319	A130D	HEMOGLOBIN K (CAMEROON)|HEMOGLOBIN J (TAICHUNG)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015228	11	5246883	11	5225653	15228	30267	rs111645889	NC_000011.10:5225652:G:T
NM_000518.4(HBB):c.388G>C (p.Ala130Pro)	HBB|LOC107133510|LOC110006319	A130P	beta Thalassemia	Likely pathogenic	criteria provided, single submitter	VCV000015146	11	5246884	11	5225654	15146	30185	rs35939430	NC_000011.10:5225653:C:G
NM_000518.4(HBB):c.386C>T (p.Ala129Val)	HBB|LOC107133510|LOC110006319	A129V	HEMOGLOBIN SITIA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015583	11	5246886	11	5225656	15583	30622	rs33957286	NC_000011.10:5225655:G:A
NM_000518.4(HBB):c.386C>A (p.Ala129Asp)	HBB|LOC107133510|LOC110006319	A129D	HEMOGLOBIN J (GUANTANAMO)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015220	11	5246886	11	5225656	15220	30259	rs33957286	NC_000011.10:5225655:G:T
NM_000518.4(HBB):c.385G>C (p.Ala129Pro)	HBB|LOC107133510|LOC110006319	A129P	HEMOGLOBIN MONT SAINT-AIGNAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015589	11	5246887	11	5225657	15589	30628	rs34139813	NC_000011.10:5225656:C:G
NM_000518.5(HBB):c.384G>C (p.Gln128His)	HBB|LOC107133510|LOC110006319	Q128H	Delta-beta-thalassemia	Uncertain significance(Last reviewed: Apr 28, 2021)	criteria provided, single submitter	VCV001098525	11	5246888	11	5225658	1098525	1087182		NC_000011.10:5225657:C:G
NM_000518.4(HBB):c.383A>G (p.Gln128Arg)	HBB|LOC107133510|LOC110006319	Q128R	HEMOGLOBIN DIEPPE|beta Thalassemia	Pathogenic; other(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000015537	11	5246889	11	5225659	15537	30576	rs33910569	NC_000011.10:5225658:T:C
NM_000518.5(HBB):c.383A>C (p.Gln128Pro)	HBB|LOC107133510|LOC110006319	Q128P	not specified	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000015409	11	5246889	11	5225659	15409	30448	rs33910569	NC_000011.10:5225658:T:G
NM_000518.4(HBB):c.382C>G (p.Gln128Glu)	HBB|LOC107133510|LOC110006319	Q128E	HEMOGLOBIN HACETTEPE|HEMOGLOBIN COMPLUTENSE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015186	11	5246890	11	5225660	15186	30225	rs33971634	NC_000011.10:5225659:G:C
NM_000518.4(HBB):c.382C>A (p.Gln128Lys)	HBB|LOC107133510|LOC110006319	Q128K	HEMOGLOBIN BREST	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015115	11	5246890	11	5225660	15115	30154	rs33971634	NC_000011.10:5225659:G:T
NM_000518.5(HBB):c.380T>G (p.Val127Gly)	HBB|LOC107133510|LOC110006319	V127G	not provided|Beta thalassemia intermedia|beta Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015483	11	5246892	11	5225662	15483	30522	rs33925391	NC_000011.10:5225661:A:C
NM_000518.5(HBB):c.380T>A (p.Val127Glu)	HBB|LOC107133510|LOC110006319	V127E	not provided|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2022)	criteria provided, conflicting interpretations	VCV000015201	11	5246892	11	5225662	15201	30240	rs33925391	NC_000011.10:5225661:A:T
NM_000518.5(HBB):c.380T>C (p.Val127Ala)	HBB|LOC107133510|LOC110006319	V127A	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2022)	criteria provided, conflicting interpretations	VCV000015106	11	5246892	11	5225662	15106	30145	rs33925391	NC_000011.10:5225661:A:G
NM_000518.5(HBB):c.379G>C (p.Val127Leu)	HBB|LOC107133510|LOC110006319	V127L	HEMOGLOBIN MOLFETTA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015597	11	5246893	11	5225663	15597	30636	rs35658323	NC_000011.10:5225662:C:G
NM_000518.4(HBB):c.374C>T (p.Pro125Leu)	HBB|LOC110006319|LOC107133510	P125L	not specified|not provided	Uncertain significance(Last reviewed: May 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015569	11	5246898	11	5225668	15569	30608	rs33983276	NC_000011.10:5225667:G:A
NM_000518.4(HBB):c.374C>A (p.Pro125Gln)	HBB|LOC107133510|LOC110006319	P125Q	not provided	Uncertain significance(Last reviewed: Jul 17, 2020)	criteria provided, single submitter	VCV000015380	11	5246898	11	5225668	15380	30419	rs33983276	NC_000011.10:5225667:G:T
NM_000518.4(HBB):c.374C>G (p.Pro125Arg)	HBB|LOC107133510|LOC110006319	P125R	Hemoglobinopathy	Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000015238	11	5246898	11	5225668	15238	30277	rs33983276	NC_000011.10:5225667:G:C
NM_000518.5(HBB):c.373C>A (p.Pro125Thr)	HBB|LOC107133510|LOC110006319	P125T	beta Thalassemia	Benign(Last reviewed: Dec 1, 2020)	no assertion criteria provided	VCV000995800	11	5246899	11	5225669	995800	983496	rs35461710	NC_000011.10:5225668:G:T
NM_000518.5(HBB):c.373C>T (p.Pro125Ser)	HBB|LOC107133510|LOC110006319	P125S	HEMOGLOBIN TUNIS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015379	11	5246899	11	5225669	15379	30418	rs35461710	NC_000011.10:5225668:G:A
NM_000518.4(HBB):c.371C>A (p.Thr124Asn)	HBB|LOC107133510|LOC110006319	T124N	not specified|beta Thalassemia|Methemoglobinemia, beta-globin type|Malaria, susceptibility to|alpha Thalassemia|Heinz body anemia|Beta-thalassemia HBB/LCRB|Hereditary persistence of fetal hemoglobin|Erythrocytosis, familial, 6|Hb SS disease|Dominant beta-thalassemia	Uncertain significance(Last reviewed: Apr 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015584	11	5246901	11	5225671	15584	30623	rs33935383	NC_000011.10:5225670:G:T
NM_000518.4(HBB):c.371C>T (p.Thr124Ile)	LOC107133510|HBB|LOC110006319	T124I	not specified	Uncertain significance(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000015385	11	5246901	11	5225671	15385	30424	rs33935383	NC_000011.10:5225670:G:A
NM_000518.5(HBB):c.367T>C (p.Phe123Leu)	HBB|LOC107133510|LOC110006319	F123L	HEMOGLOBIN BUSHEY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015580	11	5246905	11	5225675	15580	30619	rs33971848	NC_000011.10:5225674:A:G
NM_000518.4(HBB):c.365A>C (p.Glu122Ala)	HBB|LOC107133510|LOC110006319	E122A	HEMOGLOBIN D (NEATH)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015534	11	5246907	11	5225677	15534	30573	rs33987957	NC_000011.10:5225676:T:G
NM_000518.4(HBB):c.365A>G (p.Glu122Gly)	HBB|LOC107133510|LOC110006319	E122G	HEMOGLOBIN ST. FRANCIS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015501	11	5246907	11	5225677	15501	30540	rs33987957	NC_000011.10:5225676:T:C
NM_000518.4(HBB):c.365A>T (p.Glu122Val)	HBB|LOC107133510|LOC110006319	E122V	HEMOGLOBIN BEOGRAD|HEMOGLOBIN D (CAMPERDOWN)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015110	11	5246907	11	5225677	15110	30149	rs33987957	NC_000011.10:5225676:T:A
NM_000518.4(HBB):c.[29C>A;364G>C]	LOC110006319|HBB|LOC106099062|LOC107133510	E122Q, S10Y	HEMOGLOBIN D (AGRI)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446745	11|11	5246908	11|11	5225678	446745	30191|30658	rs33946267|rs33918131	NC_000011.10:5225677:C:G|NC_000011.10:5226992:G:T
NM_000518.4(HBB):c.[280T>C;364G>C]	LOC110006319|HBB|LOC106099062|LOC107133510	E122Q, C94R	HEMOGLOBIN CLEVELAND	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446740	11|11	5246908	11|11	5225678	446740	30191|30336	rs33946267|rs33972927	NC_000011.10:5225677:C:G|NC_000011.10:5226611:A:G
NM_000518.4(HBB):c.[364G>C;79G>A]	LOC110006319|HBB|LOC106099062|LOC107133510	E122Q, E27K	HEMOGLOBIN T (CAMBODIA)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000446739	11|11	5246908	11|11	5225678	446739	30191|30200	rs33946267|rs33950507	NC_000011.10:5225677:C:G|NC_000011.10:5226942:C:T
NM_000518.4(HBB):c.[20A>T;364G>A]	LOC110006319|HBB|LOC106099062|LOC107133510	E122K, E7V	Sickle cell-Hemoglobin O Arab disease	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000446736	11|11	5246908	11|11	5225678	446736	30331|30372	rs33946267|rs334	NC_000011.10:5225677:C:T|NC_000011.10:5227001:T:A
NM_000518.4(HBB):c.364G>A (p.Glu122Lys)	HBB|LOC107133510|LOC110006319	E122K	Sickle cell-Hemoglobin O Arab disease|not provided|Hb SS disease|beta Thalassemia|Beta-thalassemia HBB/LCRB|Hb SS disease|Hereditary persistence of fetal hemoglobin|Methemoglobinemia, beta-globin type|alpha Thalassemia|Heinz body anemia|Erythrocytosis, familial, 6|Dominant beta-thalassemia|Malaria, susceptibility to	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015292	11	5246908	11	5225678	15292	30331	rs33946267	NC_000011.10:5225677:C:T
NM_000518.4(HBB):c.364G>C (p.Glu122Gln)	HBB|LOC107133510|LOC110006319	E122Q	HBB-Related Disorders|Hemoglobin D disease|not provided|Hemoglobin E|Heinz body anemia|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Hb SS disease	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2022)	criteria provided, conflicting interpretations	VCV000015152	11	5246908	11	5225678	15152	30191	rs33946267	NC_000011.10:5225677:C:G
NM_000518.5(HBB):c.363A>C (p.Lys121Asn)	HBB|LOC107133510|LOC110006319	K121N	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000015329	11	5246909	11	5225679	15329	30368	rs34726542	NC_000011.10:5225678:T:G
NM_000518.5(HBB):c.362A>T (p.Lys121Ile)	HBB|LOC107133510|LOC110006319	K121I	HEMOGLOBIN JIANGHUA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015229	11	5246910	11	5225680	15229	30268	rs34303736	NC_000011.10:5225679:T:A
NM_000518.4(HBB):c.361A>C (p.Lys121Gln)	HBB|LOC107133510|LOC110006319	K121Q	HEMOGLOBIN TAKAMATSU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015370	11	5246911	11	5225681	15370	30409	rs33924134	NC_000011.10:5225680:T:G
NM_000518.4(HBB):c.361A>G (p.Lys121Glu)	HBB|LOC107133510|LOC110006319	K121E	HEMOGLOBIN HIJIYAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015195	11	5246911	11	5225681	15195	30234	rs33924134	NC_000011.10:5225680:T:C
NM_000518.4(HBB):c.[334G>C;359G>A]	HBB|LOC107133510|LOC110006319	G120D, V112L	HEMOGLOBIN FANNIN-LUBBOCK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446732	11|11	5246913	11|11	5225683	446732	38469|30204	rs33947020|rs33957964	NC_000011.10:5225682:C:T|NC_000011.10:5225707:C:G
NM_000518.5(HBB):c.359G>A (p.Gly120Asp)	HBB|LOC107133510|LOC110006319	G120D	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 10, 2022)	criteria provided, conflicting interpretations	VCV000242712	11	5246913	11	5225683	242712	38469	rs33947020	NC_000011.10:5225682:C:T
NM_000518.4(HBB):c.359G>C (p.Gly120Ala)	HBB|LOC107133510|LOC110006319	G120A	HEMOGLOBIN IOWA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015484	11	5246913	11	5225683	15484	30523	rs33947020	NC_000011.10:5225682:C:G
NM_000518.4(HBB):c.359G>T (p.Gly120Val)	HBB|LOC110006319|LOC107133510	G120V	HEMOGLOBIN BOUGARDIREY-MALI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015109	11	5246913	11	5225683	15109	30148	rs33947020	NC_000011.10:5225682:C:A
NM_000518.4(HBB):c.356T>G (p.Phe119Cys)	HBB|LOC107133510|LOC110006319	F119C	HEMOGLOBIN HARROW	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015574	11	5246916	11	5225686	15574	30613	rs33928092	NC_000011.10:5225685:A:C
NM_000518.4(HBB):c.356T>A (p.Phe119Tyr)	HBB|LOC107133510|LOC110006319	F119Y	HEMOGLOBIN MINNEAPOLIS-LAOS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015266	11	5246916	11	5225686	15266	30305	rs33928092	NC_000011.10:5225685:A:T
NM_000518.5(HBB):c.353A>G (p.His118Arg)	HBB|LOC107133510|LOC110006319	H118R	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 17, 2022)	criteria provided, conflicting interpretations	VCV000036324	11	5246919	11	5225689	36324	44988	rs33935673	NC_000011.10:5225688:T:C
NM_000518.5(HBB):c.351T>A (p.His117Gln)	HBB|LOC107133510|LOC110006319	H117Q	not specified	Uncertain significance(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000439157	11	5246921	11	5225691	439157	432674	rs35209776	NC_000011.10:5225690:A:T
NM_000518.5(HBB):c.351T>R (p.His117Gln)	HBB|LOC107133510|LOC110006319	H117Q	HEMOGLOBIN HAFNIA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015187	11	5246921	11	5225691	15187	30226	rs35209776	NC_000011.10:5225690:A:Y
NM_000518.5(HBB):c.350A>C (p.His117Pro)	HBB|LOC107133510|LOC110006319	H117P	HEMOGLOBIN SAITAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015340	11	5246922	11	5225692	15340	30379	rs33978082	NC_000011.10:5225691:T:G
NM_000518.5(HBB):c.350A>G (p.His117Arg)	HBB|LOC107133510|LOC110006319	H117R	HEMOGLOBIN P|HEMOGLOBIN P (GALVESTON)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015303	11	5246922	11	5225692	15303	30342	rs33978082	NC_000011.10:5225691:T:C
NM_000518.5(HBB):c.349C>T (p.His117Tyr)	HBB|LOC107133510|LOC110006319	H117Y	HEMOGLOBIN TSUKUMI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015582	11	5246923	11	5225693	15582	30621	rs34049764	NC_000011.10:5225692:G:A
NM_000518.5(HBB):c.347C>A (p.Ala116Asp)	HBB|LOC107133510|LOC110006319	A116D	not provided	Pathogenic(Last reviewed: May 17, 2021)	criteria provided, single submitter	VCV000015526	11	5246925	11	5225695	15526	30565	rs35485099	NC_000011.10:5225694:G:T
NM_000518.5(HBB):c.346G>C (p.Ala116Pro)	HBB|LOC107133510|LOC110006319	A116P	HEMOGLOBIN MADRID	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015257	11	5246926	11	5225696	15257	30296	rs34945623	NC_000011.10:5225695:C:G
NM_000518.5(HBB):c.344T>C (p.Leu115Pro)	HBB|LOC107133510|LOC110006319	L115P	not provided|Dominant beta-thalassemia	Pathogenic(Last reviewed: Mar 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015513	11	5246928	11	5225698	15513	30552	rs36015961	NC_000011.10:5225697:A:G
NM_000518.4(HBB):c.[343C>A;359G>A]	HBB|LOC107133510|LOC110006319	L115M, G120D	HEMOGLOBIN MASUDA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446733	11|11	5246929	11|11	5225699	446733	30525|38469	rs33917394|rs33947020	NC_000011.10:5225698:G:T|NC_000011.10:5225682:C:T
NM_000518.5(HBB):c.343C>A (p.Leu115Met)	HBB|LOC107133510|LOC110006319	L115M	HEMOGLOBIN ZENGCHENG	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015486	11	5246929	11	5225699	15486	30525	rs33917394	NC_000011.10:5225698:G:T
NM_000518.5(HBB):c.341T>A (p.Val114Glu)	HBB|LOC107133510|LOC110006319	V114E	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2022)	criteria provided, conflicting interpretations	VCV000015286	11	5246931	11	5225701	15286	30325	rs34484056	NC_000011.10:5225700:A:T
NM_000518.4(HBB):c.338G>T (p.Cys113Phe)	HBB|LOC107133510|LOC110006319	C113F	HEMOGLOBIN CANTERBURY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015595	11	5246934	11	5225704	15595	30634	rs33932908	NC_000011.10:5225703:C:A
NM_000518.4(HBB):c.338G>A (p.Cys113Tyr)	HBB|LOC107133510|LOC110006319	C113Y	HEMOGLOBIN YAHATA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015502	11	5246934	11	5225704	15502	30541	rs33932908	NC_000011.10:5225703:C:T
NM_000518.5(HBB):c.337T>C (p.Cys113Arg)	HBB|LOC107133510|LOC110006319	C113R	HEMOGLOBIN INDIANAPOLIS|Heinz body anemia	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015207	11	5246935	11	5225705	15207	30246	rs35849199	NC_000011.10:5225704:A:G
NM_000518.5(HBB):c.335T>C (p.Val112Ala)	HBB|LOC107133510|LOC110006319	V112A	HEMOGLOBIN STANMORE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015357	11	5246937	11	5225707	15357	30396	rs35871407	NC_000011.10:5225706:A:G
NM_000518.5(HBB):c.334G>C (p.Val112Leu)	HBB|LOC107133510|LOC110006319	V112L	not provided	Likely benign(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV000478878	11	5246938	11	5225708	478878	30204	rs33957964	NC_000011.10:5225707:C:G
NM_000518.4(HBB):c.334G>T (p.Val112Phe)	HBB|LOC107133510|LOC110006319	V112F	HEMOGLOBIN PETERBOROUGH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015309	11	5246938	11	5225708	15309	30348	rs33957964	NC_000011.10:5225707:C:A
NM_000518.4(HBB):c.332T>C (p.Leu111Pro)	HBB|LOC107133510|LOC110006319	L111P	not provided|beta Thalassemia|Hb SS disease	Pathogenic(Last reviewed: Jun 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015352	11	5246940	11	5225710	15352	30391	rs35256489	NC_000011.10:5225709:A:G
NM_000518.5(HBB):c.328G>A (p.Val110Met)	LOC110006319|HBB|LOC107133510	V110M	Hemoglobinopathy|not specified|beta Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015342	11	5246944	11	5225714	15342	30381	rs33969677	NC_000011.10:5225713:C:T
NM_000518.5(HBB):c.328G>C (p.Val110Leu)	HBB|LOC107133510|LOC110006319	V110L	not provided	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000015230	11	5246944	11	5225714	15230	30269	rs33969677	NC_000011.10:5225713:C:G
NM_000518.5(HBB):c.327C>R (p.Asn109Lys)	HBB|LOC107133510|LOC110006319	N109K	HEMOGLOBIN PRESBYTERIAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015318	11	5246945	11	5225715	15318	30357	rs34933751	NC_000011.10:5225714:G:Y
NM_000518.5(HBB):c.325A>G (p.Asn109Asp)	HBB|LOC107133510|LOC110006319	N109D	HEMOGLOBIN YOSHIZUKA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015396	11	5246947	11	5225717	15396	30435	rs33958637	NC_000011.10:5225716:T:C
NM_000518.5(HBB):c.323G>T (p.Gly108Val)	HBB|LOC107133510|LOC110006319	G108V	not specified	Uncertain significance(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000633260	11	5246949	11	5225719	633260	621359	rs35519485	NC_000011.10:5225718:C:A
NM_000518.5(HBB):c.322G>C (p.Gly108Arg)	HBB|LOC107133510|LOC110006319	G108R	HEMOGLOBIN BURKE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015124	11	5246950	11	5225720	15124	30163	rs35017910	NC_000011.10:5225719:C:G
NM_000518.4(HBB):c.320T>G (p.Leu107Arg)	HBB|LOC107133510|LOC110006319	L107R	HEMOGLOBIN TERRE HAUTE|Beta-plus-thalassemia	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015487	11	5246952	11	5225722	15487	30526	rs33941844	NC_000011.10:5225721:A:C
NM_000518.4(HBB):c.320T>A (p.Leu107Gln)	LOC107133510|LOC110006319|HBB	L107Q	Methemoglobinemia, beta-globin type	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000015378	11	5246952	11	5225722	15378	30417	rs33941844	NC_000011.10:5225721:A:T
NM_000518.4(HBB):c.320T>C (p.Leu107Pro)	HBB|LOC107133510|LOC110006319	L107P	HEMOGLOBIN CASPER|HEMOGLOBIN SOUTHAMPTON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015356	11	5246952	11	5225722	15356	30395	rs33941844	NC_000011.10:5225721:A:G
NM_000518.5(HBB):c.319C>G (p.Leu107Val)	HBB|LOC107133510|LOC110006319	L107V	not provided	Uncertain significance(Last reviewed: Apr 19, 2020)	criteria provided, single submitter	VCV000869278	11	5246953	11	5225723	869278	857444	rs63750596	NC_000011.10:5225722:G:C
NM_000518.5(HBB):c.316C>T (p.Leu106Phe)	HBB|LOC107133510|LOC110006319	L106F	not specified	Uncertain significance(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000015480	11	5246956	11	5225726	15480	30519	rs34022507	NC_000011.10:5225725:G:A
NM_000518.4(HBB):c.[278A>C;315G>Y]	LOC110006319|HBB|LOC106099062|LOC107133510	R105S, H93P	HEMOGLOBIN DUINO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446742	11|11	5247807	11|11	5226577	446742	30169|30326	rs33914944|rs33974325	NC_000011.10:5226576:C:R|NC_000011.10:5226613:T:G
NM_000518.5(HBB):c.315G>T (p.Arg105Ser)	LOC110006319|HBB|LOC106099062|LOC107133510	R105S	not specified	Uncertain significance(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000439779	11	5247807	11	5226577	439779	433085	rs33914944	NC_000011.10:5226576:C:A
NM_000518.5(HBB):c.315G>C (p.Arg105Ser)	HBB|LOC106099062|LOC107133510|LOC110006319	R105S	not specified	Uncertain significance(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	VCV000015525	11	5247807	11	5226577	15525	30564	rs33914944	NC_000011.10:5226576:C:G
NM_000518.5(HBB):c.315G>Y (p.Arg105Ser)	HBB|LOC106099062|LOC107133510|LOC110006319	R105S	HEMOGLOBIN CAMPERDOWN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015130	11	5247807	11	5226577	15130	30169	rs33914944	NC_000011.10:5226576:C:R
NM_000518.5(HBB):c.314G>C (p.Arg105Thr)	LOC110006319|LOC107133510|LOC106099062|HBB	R105T	not specified	Likely benign(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000015351	11	5247808	11	5226578	15351	30390	rs33911434	NC_000011.10:5226577:C:G
NM_000518.5(HBB):c.312C>G (p.Phe104Leu)	HBB|LOC106099062|LOC107133510|LOC110006319	F104L	HEMOGLOBIN HEATHROW|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015192	11	5247810	11	5226580	15192	30231	rs35067717	NC_000011.10:5226579:G:C
NM_000518.4(HBB):c.310T>G (p.Phe104Val)	HBB|LOC106099062|LOC107133510|LOC110006319	F104V	HEMOGLOBIN SPARTA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015608	11	5247812	11	5226582	15608	30647	rs33921589	NC_000011.10:5226581:A:C
NM_000518.4(HBB):c.310T>A (p.Phe104Ile)	HBB|LOC106099062|LOC107133510|LOC110006319	F104I	HEMOGLOBIN SAINT NAZAIRE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015524	11	5247812	11	5226582	15524	30563	rs33921589	NC_000011.10:5226581:A:T
NM_000518.5(HBB):c.309C>A (p.Asn103Lys)	LOC110006319|HBB|LOC106099062|LOC107133510	N103K	not provided	Uncertain significance(Last reviewed: Apr 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000036311	11	5247813	11	5226583	36311	44975	rs34227486	NC_000011.10:5226582:G:T
NM_000518.5(HBB):c.309C>R (p.Asn103Lys)	LOC110006319|HBB|LOC106099062|LOC107133510	N103K	HEMOGLOBIN RICHMOND	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015326	11	5247813	11	5226583	15326	30365		NC_000011.10:5226582:G:Y
NM_000518.4(HBB):c.308A>C (p.Asn103Thr)	HBB|LOC106099062|LOC107133510|LOC110006319	N103T	not specified	Benign(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015235	11	5247814	11	5226584	15235	30274	rs33948057	NC_000011.10:5226583:T:G
NM_000518.4(HBB):c.308A>G (p.Asn103Ser)	LOC106099062|LOC107133510|LOC110006319|HBB	N103S	HEMOGLOBIN BETH ISRAEL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015111	11	5247814	11	5226584	15111	30150	rs33948057	NC_000011.10:5226583:T:C
NM_000518.5(HBB):c.307A>G (p.Asn103Asp)	LOC110006319|HBB|LOC106099062|LOC107133510	N103D	not specified	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000811863	11	5247815	11	5226585	811863	799650	rs33927739	NC_000011.10:5226584:T:C
NM_000518.5(HBB):c.307A>T (p.Asn103Tyr)	HBB|LOC106099062|LOC107133510|LOC110006319	N103Y	HEMOGLOBIN ST. MANDE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015354	11	5247815	11	5226585	15354	30393	rs33927739	NC_000011.10:5226584:T:A
NM_000518.5(HBB):c.306G>T (p.Glu102Asp)	LOC106099062|HBB|LOC110006319|LOC107133510	E102D	not provided	Uncertain significance(Last reviewed: Feb 22, 2022)	criteria provided, single submitter	VCV002432366	11	5247816	11	5226586	2432366	2412875		NC_000011.10:5226585:C:A
NM_000518.5(HBB):c.306G>C (p.Glu102Asp)	HBB|LOC106099062|LOC107133510|LOC110006319	E102D	HEMOGLOBIN POTOMAC|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015317	11	5247816	11	5226586	15317	30356	rs35209591	NC_000011.10:5226585:C:G
NM_000518.5(HBB):c.305A>G (p.Glu102Gly)	LOC106099062|LOC107133510|LOC110006319|HBB	E102G	Erythrocytosis, familial, 6|HEMOGLOBIN ALBERTA	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015094	11	5247817	11	5226587	15094	30133	rs33937393	NC_000011.10:5226586:T:C
NM_000518.4(HBB):c.304G>C (p.Glu102Gln)	HBB|LOC106099062|LOC107133510|LOC110006319	E102Q	HEMOGLOBIN RUSH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015332	11	5247818	11	5226588	15332	30371	rs33966487	NC_000011.10:5226587:C:G
NM_000518.4(HBB):c.304G>A (p.Glu102Lys)	LOC110006319|LOC107133510|HBB|LOC106099062	E102K	Erythrocytosis, familial, 6|HEMOGLOBIN BRITISH COLUMBIA	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015118	11	5247818	11	5226588	15118	30157	rs33966487	NC_000011.10:5226587:C:T
NM_000518.4(HBB):c.302C>G (p.Pro101Arg)	HBB|LOC106099062|LOC107133510|LOC110006319	P101R	not provided	Uncertain significance(Last reviewed: Nov 15, 2021)	criteria provided, single submitter	VCV000015285	11	5247820	11	5226590	15285	30324	rs33965000	NC_000011.10:5226589:G:C
NM_000518.4(HBB):c.302C>T (p.Pro101Leu)	HBB|LOC106099062|LOC107133510|LOC110006319	P101L	Erythrocytosis, familial, 6|HEMOGLOBIN BRIGHAM	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015116	11	5247820	11	5226590	15116	30155	rs33965000	NC_000011.10:5226589:G:A
NM_000518.5(HBB):c.300T>A (p.Asp100Glu)	HBB|LOC106099062|LOC107133510	D100E	Erythrocytosis, familial, 6	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000917854	11	5247822	11	5226592	917854	906174	rs34013622	NC_000011.10:5226591:A:T
NM_000518.5(HBB):c.300T>R (p.Asp100Glu)	HBB|LOC106099062|LOC107133510	D100E	HEMOGLOBIN COIMBRA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015495	11	5247822	11	5226592	15495	30534	rs34013622	NC_000011.10:5226591:A:Y
NM_000518.4(HBB):c.299A>C (p.Asp100Ala)	HBB|LOC106099062|LOC107133510	D100A	HEMOGLOBIN RADCLIFFE|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015315	11	5247823	11	5226593	15315	30354	rs33971048	NC_000011.10:5226592:T:G
NM_000518.4(HBB):c.299A>G (p.Asp100Gly)	HBB|LOC106099062|LOC107133510	D100G	HEMOGLOBIN HOTEL-DIEU|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015204	11	5247823	11	5226593	15204	30243	rs33971048	NC_000011.10:5226592:T:C
NM_000518.4(HBB):c.299A>T (p.Asp100Val)	HBB|LOC106099062|LOC107133510	D100V	HEMOGLOBIN CHEMILLY|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015134	11	5247823	11	5226593	15134	30173	rs33971048	NC_000011.10:5226592:T:A
NM_000518.4(HBB):c.298G>T (p.Asp100Tyr)	HBB|LOC106099062|LOC107133510	D100Y	Erythrocytosis, familial, 6|HEMOGLOBIN YPSILANTI	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015397	11	5247824	11	5226594	15397	30436	rs33954595	NC_000011.10:5226593:C:A
NM_000518.4(HBB):c.298G>C (p.Asp100His)	HBB|LOC106099062|LOC107133510	D100H	Erythrocytosis, familial, 6|HEMOGLOBIN YAKIMA	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015391	11	5247824	11	5226594	15391	30430	rs33954595	NC_000011.10:5226593:C:G
NM_000518.4(HBB):c.298G>A (p.Asp100Asn)	HBB|LOC106099062|LOC107133510	D100N	HEMOGLOBIN KEMPSEY|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015236	11	5247824	11	5226594	15236	30275	rs33954595	NC_000011.10:5226593:C:T
NM_000518.4(HBB):c.296T>G (p.Val99Gly)	HBB|LOC106099062|LOC107133510	V99G	HEMOGLOBIN NOTTINGHAM	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015291	11	5247826	11	5226596	15291	30330	rs33985510	NC_000011.10:5226595:A:C
NM_000518.4(HBB):c.296T>C (p.Val99Ala)	HBB|LOC106099062|LOC107133510	V99A	HEMOGLOBIN DJELFA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015158	11	5247826	11	5226596	15158	30197	rs33985510	NC_000011.10:5226595:A:G
NM_000518.4(HBB):c.[295G>A;98T>A]	LOC106099062|LOC107133510|HBB	V99M, L33Q	HEMOGLOBIN MEDICINE LAKE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446743	11|11	5247827	11|11	5226597	446743	30280|30572	rs33933298|rs33948578	NC_000011.10:5226596:C:T|NC_000011.10:5226793:A:T
NM_000518.5(HBB):c.295G>A (p.Val99Met)	HBB|LOC106099062|LOC107133510	V99M	Hemoglobinopathy|not provided	Pathogenic(Last reviewed: Oct 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015241	11	5247827	11	5226597	15241	30280	rs33933298	NC_000011.10:5226596:C:T
NM_000518.5(HBB):c.294C>G (p.His98Gln)	HBB|LOC106099062|LOC107133510	H98Q	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000801186	11	5247828	11	5226598	801186	789498	rs34515413	NC_000011.10:5226597:G:C
NM_000518.5(HBB):c.294C>R (p.His98Gln)	HBB|LOC106099062|LOC107133510	H98Q	Erythrocytosis, familial, 6|HEMOGLOBIN MALMO	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015259	11	5247828	11	5226598	15259	30298	rs34515413	NC_000011.10:5226597:G:Y
NM_000518.4(HBB):c.293A>T (p.His98Leu)	HBB|LOC106099062|LOC107133510	H98L	Erythrocytosis, familial, 6|HEMOGLOBIN WOOD	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015390	11	5247829	11	5226599	15390	30429	rs33951978	NC_000011.10:5226598:T:A
NM_000518.4(HBB):c.293A>C (p.His98Pro)	HBB|LOC106099062|LOC107133510	H98P	HEMOGLOBIN NAGOYA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015283	11	5247829	11	5226599	15283	30322	rs33951978	NC_000011.10:5226598:T:G
NM_000518.4(HBB):c.292C>A (p.His98Asn)	HBB|LOC106099062|LOC107133510	H98N	HEMOGLOBIN SANTA CLARA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015607	11	5247830	11	5226600	15607	30646	rs33950993	NC_000011.10:5226599:G:T
NM_000518.4(HBB):c.292C>T (p.His98Tyr)	HBB|LOC106099062|LOC107133510	H98Y	HEMOGLOBIN MORIGUCHI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015274	11	5247830	11	5226600	15274	30313	rs33950993	NC_000011.10:5226599:G:A
NM_000518.5(HBB):c.289_290delinsGG (p.Leu97Gly)	LOC106099062|LOC107133510|HBB	L97G	not provided	Uncertain significance(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV002432365	11	5247832 - 5247833	11	5226602 - 5226603	2432365	2412874		NC_000011.10:5226601:AG:CC
NM_000518.5(HBB):c.290T>C (p.Leu97Pro)	HBB|LOC106099062|LOC107133510	L97P	HEMOGLOBIN DEBROUSSE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015550	11	5247832	11	5226602	15550	30589	rs36081208	NC_000011.10:5226601:A:G
NM_000518.5(HBB):c.289C>G (p.Leu97Val)	HBB|LOC106099062|LOC107133510	L97V	HEMOGLOBIN REGINA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015325	11	5247833	11	5226603	15325	30364	rs34665886	NC_000011.10:5226602:G:C
NM_000518.5(HBB):c.288G>C (p.Lys96Asn)	HBB|LOC106099062|LOC107133510	K96N	HEMOGLOBIN DETROIT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015157	11	5247834	11	5226604	15157	30196	rs36038739	NC_000011.10:5226603:C:G
NM_000518.5(HBB):c.287A>T (p.Lys96Met)	HBB|LOC106099062|LOC107133510	K96M	HEMOGLOBIN J (CORDOBA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015218	11	5247835	11	5226605	15218	30257	rs35204496	NC_000011.10:5226604:T:A
NM_000518.5(HBB):c.286A>G (p.Lys96Glu)	HBB|LOC106099062|LOC107133510	K96E	not specified|not provided	Likely benign(Last reviewed: Oct 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015278	11	5247836	11	5226606	15278	30317	rs33914359	NC_000011.10:5226605:T:C
NM_000518.5(HBB):c.284A>G (p.Asp95Gly)	HBB|LOC106099062|LOC107133510	D95G	HEMOGLOBIN CHANDIGARH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015133	11	5247838	11	5226608	15133	30172	rs34579351	NC_000011.10:5226607:T:C
NM_000518.4(HBB):c.283G>T (p.Asp95Tyr)	HBB|LOC106099062|LOC107133510	D95Y	HEMOGLOBIN GELDROP ST. ANNA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015620	11	5247839	11	5226609	15620	30659	rs33959340	NC_000011.10:5226608:C:A
NM_000518.4(HBB):c.283G>A (p.Asp95Asn)	HBB|LOC106099062|LOC107133510	D95N	not specified|not provided	Uncertain significance(Last reviewed: Dec 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015123	11	5247839	11	5226609	15123	30162	rs33959340	NC_000011.10:5226608:C:T
NM_000518.4(HBB):c.283G>C (p.Asp95His)	LOC106099062|LOC107133510|HBB	D95H	Erythrocytosis, familial, 6|HEMOGLOBIN BARCELONA	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015104	11	5247839	11	5226609	15104	30143	rs33959340	NC_000011.10:5226608:C:G
NM_000518.5(HBB):c.282T>G (p.Cys94Trp)	HBB|LOC106099062|LOC107133510	C94W	not specified	Uncertain significance(Last reviewed: Jan 15, 2021)	criteria provided, single submitter	VCV000996273	11	5247840	11	5226610	996273	983971	rs1847552343	NC_000011.10:5226609:A:C
NM_000518.5(HBB):c.280T>C (p.Cys94Arg)	HBB|LOC106099062|LOC107133510	C94R	HEMOGLOBIN OKAZAKI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015297	11	5247842	11	5226612	15297	30336	rs33972927	NC_000011.10:5226611:A:G
NM_000518.5(HBB):c.279C>A (p.His93Gln)	HBB|LOC106099062|LOC107133510	H93Q	not provided	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000811500	11	5247843	11	5226613	811500	799651	rs34083951	NC_000011.10:5226612:G:T
NM_000518.5(HBB):c.279C>R (p.His93Gln)	HBB|LOC106099062|LOC107133510	H93Q	HEMOGLOBIN SAINT ETIENNE	Pathogenic(Last reviewed: Jun 1, 1985)	no assertion criteria provided	VCV000015208	11	5247843	11	5226613	15208	30247	rs34083951	NC_000011.10:5226612:G:Y
NM_000518.4(HBB):c.278A>C (p.His93Pro)	HBB|LOC106099062|LOC107133510	H93P	HEMOGLOBIN NEWCASTLE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015287	11	5247844	11	5226614	15287	30326	rs33974325	NC_000011.10:5226613:T:G
NM_000518.4(HBB):c.278A>G (p.His93Arg)	HBB|LOC106099062|LOC107133510	H93R	HEMOGLOBIN MOZHAISK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015276	11	5247844	11	5226614	15276	30315	rs33974325	NC_000011.10:5226613:T:C
NM_000518.4(HBB):c.277C>A (p.His93Asn)	HBB|LOC106099062|LOC107133510	H93N	Hemoglobinopathy	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015494	11	5247845	11	5226615	15494	30533	rs33924775	NC_000011.10:5226614:G:T
NM_000518.4(HBB):c.277C>T (p.His93Tyr)	HBB|LOC106099062|LOC107133510	H93Y	HEMOGLOBIN M (MILWAUKEE 2)|HEMOGLOBIN M (HYDE PARK)|HEMOGLOBIN M (AKITA)|Methemoglobinemia, beta-globin type	Pathogenic; other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015255	11	5247845	11	5226615	15255	30294	rs33924775	NC_000011.10:5226614:G:A
NM_000518.4(HBB):c.277C>G (p.His93Asp)	HBB|LOC106099062|LOC107133510	H93D	HEMOGLOBIN J (ALTGELD GARDENS)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015209	11	5247845	11	5226615	15209	30248	rs33924775	NC_000011.10:5226614:G:C
NM_000518.4(HBB):c.275T>C (p.Leu92Pro)	LOC106099062|HBB|LOC107133510	L92P	not specified	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000015338	11	5247847	11	5226617	15338	30377	rs33917785	NC_000011.10:5226616:A:G
NM_000518.4(HBB):c.275T>G (p.Leu92Arg)	HBB|LOC106099062|LOC107133510	L92R	not provided	Uncertain significance(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015131	11	5247847	11	5226617	15131	30170	rs33917785	NC_000011.10:5226616:A:C
NM_000518.5(HBB):c.273G>C (p.Glu91Asp)	HBB|LOC106099062|LOC107133510	E91D	HEMOGLOBIN PIERRE-BENITE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015311	11	5247849	11	5226619	15311	30350	rs35002698	NC_000011.10:5226618:C:G
NM_000518.5(HBB):c.272A>G (p.Glu91Gly)	HBB|LOC106099062|LOC107133510	E91G	HEMOGLOBIN ROSEAU-POINTE A PITRE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015330	11	5247850	11	5226620	15330	30369	rs35068498	NC_000011.10:5226619:T:C
NM_000518.4(HBB):c.[20A>T;271G>A]	HBB|LOC106099062|LOC107133510	E91K, E7V	HEMOGLOBIN S (CAMEROON)	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000446747	11|11	5247851	11|11	5226621	446747	30130|30372	rs33913712|rs334	NC_000011.10:5226620:C:T|NC_000011.10:5227001:T:A
NM_000518.4(HBB):c.271G>A (p.Glu91Lys)	HBB|LOC106099062|LOC107133510	E91K	not specified|not provided	Uncertain significance(Last reviewed: Jan 16, 2023)	criteria provided, multiple submitters, no conflicts	VCV000015091	11	5247851	11	5226621	15091	30130	rs33913712	NC_000011.10:5226620:C:T
NM_000518.4(HBB):c.269G>C (p.Ser90Thr)	HBB|LOC106099062|LOC107133510	S90T	HEMOGLOBIN VILLAVERDE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015528	11	5247853	11	5226623	15528	30567	rs33917628	NC_000011.10:5226622:C:G
NM_000518.4(HBB):c.269G>A (p.Ser90Asn)	HBB|LOC106099062|LOC107133510	S90N	Erythrocytosis, familial, 6|HEMOGLOBIN CRETEIL|beta Thalassemia	Pathogenic/Likely pathogenic; other(Last reviewed: Jun 10, 2020)	no assertion criteria provided	VCV000015147	11	5247853	11	5226623	15147	30186	rs33917628	NC_000011.10:5226622:C:T
NM_000518.5(HBB):c.268A>C (p.Ser90Arg)	HBB|LOC106099062|LOC107133510	S90R	HEMOGLOBIN VANDERBILT|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015383	11	5247854	11	5226624	15383	30422	rs35351128	NC_000011.10:5226623:T:G
NM_000518.4(HBB):c.266T>C (p.Leu89Pro)	HBB|LOC107133510|LOC106099062	L89P	Beta-thalassemia HBB/LCRB|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015343	11	5247856	11	5226626	15343	30382	rs33940204	NC_000011.10:5226625:A:G
NM_000518.4(HBB):c.266T>G (p.Leu89Arg)	HBB|LOC106099062|LOC107133510	L89R	HEMOGLOBIN BORAS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015108	11	5247856	11	5226626	15108	30147	rs33940204	NC_000011.10:5226625:A:C
NM_000518.4(HBB):c.263C>T (p.Thr88Ile)	HBB|LOC106099062|LOC107133510	T88I	not specified	Benign(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015493	11	5247859	11	5226629	15493	30532	rs33993568	NC_000011.10:5226628:G:A
NM_000518.4(HBB):c.263C>A (p.Thr88Lys)	LOC106099062|LOC107133510|HBB	T88K	not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2021)	criteria provided, conflicting interpretations	VCV000015150	11	5247859	11	5226629	15150	30189	rs33993568	NC_000011.10:5226628:G:T
NM_000518.5(HBB):c.262A>C (p.Thr88Pro)	HBB|LOC107133510|LOC106099062	T88P	not specified|beta Thalassemia|Hb SS disease|Beta-thalassemia HBB/LCRB|Heinz body anemia|Hereditary persistence of fetal hemoglobin|Malaria, susceptibility to|alpha Thalassemia|Erythrocytosis, familial, 6|Methemoglobinemia, beta-globin type|Dominant beta-thalassemia	Benign/Likely benign(Last reviewed: Jun 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015489	11	5247860	11	5226630	15489	30528	rs35553496	NC_000011.10:5226629:T:G
NM_000518.5(HBB):c.260C>T (p.Ala87Val)	LOC106099062|HBB|LOC107133510	A87V	not provided	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000993072	11	5247862	11	5226632	993072	981060	rs35819837	NC_000011.10:5226631:G:A
NM_000518.5(HBB):c.260C>A (p.Ala87Asp)	HBB|LOC106099062|LOC107133510	A87D	HEMOGLOBIN OLOMOUC	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015299	11	5247862	11	5226632	15299	30338	rs35819837	NC_000011.10:5226631:G:T
NM_000518.5(HBB):c.259G>C (p.Ala87Pro)	HBB|LOC106099062|LOC107133510	A87P	HEMOGLOBIN CARDARELLI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015611	11	5247863	11	5226633	15611	30650	rs33952147	NC_000011.10:5226632:C:G
NM_000518.5(HBB):c.257T>C (p.Phe86Ser)	LOC106099062|HBB|LOC107133510	F86S	not provided	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV000015122	11	5247865	11	5226635	15122	30161	rs35693898	NC_000011.10:5226634:A:G
NM_000518.5(HBB):c.254C>T (p.Thr85Ile)	HBB|LOC106099062|LOC107133510	T85I	HEMOGLOBIN KOFU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015240	11	5247868	11	5226638	15240	30279	rs35914488	NC_000011.10:5226637:G:A
NM_000518.5(HBB):c.253A>G (p.Thr85Ala)	HBB|LOC106099062|LOC107133510	T85A	not provided	Uncertain significance(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000015579	11	5247869	11	5226639	15579	30618	rs35960772	NC_000011.10:5226638:T:C
NM_000518.5(HBB):c.251G>A (p.Gly84Asp)	HBB|LOC106099062|LOC107133510	G84D	not provided	Likely benign(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000015320	11	5247871	11	5226641	15320	30359	rs1803195	NC_000011.10:5226640:C:T
NM_000518.5(HBB):c.250G>C (p.Gly84Arg)	HBB|LOC106099062|LOC107133510	G84R	not provided	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000015521	11	5247872	11	5226642	15521	30560	rs33930385	NC_000011.10:5226641:C:G
NM_000518.5(HBB):c.250G>T (p.Gly84Cys)	HBB|LOC106099062|LOC107133510	G84C	not provided	Uncertain significance(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000015367	11	5247872	11	5226642	15367	30406	rs33930385	NC_000011.10:5226641:C:A
NM_000518.5(HBB):c.249G>C (p.Lys83Asn)	LOC106099062|LOC107133510|HBB	K83N	not provided	Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000618675	11	5247873	11	5226643	618675	609790	rs33991993	NC_000011.10:5226642:C:G
NM_000518.4(HBB):c.[20A>T;249G>Y]	HBB|LOC106099062|LOC107133510	K83N, E7V	HEMOGLOBIN S (PROVIDENCE)	Pathogenic(Last reviewed: Oct 1, 1988)	no assertion criteria provided	VCV000446737	11|11	5247873	11|11	5226643	446737	30358|30372	rs33991993|rs334	NC_000011.10:5226642:C:R|NC_000011.10:5227001:T:A
NM_000518.5(HBB):c.249G>Y (p.Lys83Asn)	HBB|LOC106099062|LOC107133510	K83N	Erythrocytosis, familial, 6|HEMOGLOBIN PROVIDENCE	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015319	11	5247873	11	5226643	15319	30358	rs33991993	NC_000011.10:5226642:C:R
NM_000518.4(HBB):c.248A>C (p.Lys83Thr)	HBB|LOC106099062|LOC107133510	K83T	HEMOGLOBIN RAHERE|Erythrocytosis, familial, 6	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015321	11	5247874	11	5226644	15321	30360	rs33987903	NC_000011.10:5226643:T:G
NM_000518.4(HBB):c.248A>T (p.Lys83Met)	HBB|LOC106099062|LOC107133510	K83M	not provided	Pathogenic(Last reviewed: Mar 12, 2021)	criteria provided, single submitter	VCV000015193	11	5247874	11	5226644	15193	30232	rs33987903	NC_000011.10:5226643:T:A
NM_000518.4(HBB):c.247A>G (p.Lys83Glu)	HBB|LOC106099062|LOC107133510	K83E	Hb gambara	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000015561	11	5247875	11	5226645	15561	30600	rs33940051	NC_000011.10:5226644:T:C
NM_000518.4(HBB):c.247A>C (p.Lys83Gln)	HBB|LOC106099062|LOC107133510	K83Q	HEMOGLOBIN TSURUMAI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015552	11	5247875	11	5226645	15552	30591	rs33940051	NC_000011.10:5226644:T:G
NM_000518.4(HBB):c.245T>A (p.Leu82His)	HBB|LOC106099062|LOC107133510	L82H	HEMOGLOBIN LA ROCHE-SUR-YON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015570	11	5247877	11	5226647	15570	30609	rs33936967	NC_000011.10:5226646:A:T
NM_000518.4(HBB):c.245T>G (p.Leu82Arg)	LOC106099062|LOC107133510|HBB	L82R	HEMOGLOBIN BAYLOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015105	11	5247877	11	5226647	15105	30144	rs33936967	NC_000011.10:5226646:A:C
NM_000518.5(HBB):c.244C>T (p.Leu82Phe)	LOC106099062|LOC107133510|HBB	L82F	not provided	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000619857	11	5247878	11	5226648	619857	611096	rs11549406	NC_000011.10:5226647:G:A
NM_000518.5(HBB):c.243C>A (p.Asn81Lys)	HBB|LOC106099062|LOC107133510	N81K	HEMOGLOBIN G (SZUHU)|HEMOGLOBIN GIFU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015177	11	5247879	11	5226649	15177	30216	rs35890380	NC_000011.10:5226648:G:T
NM_000518.5(HBB):c.241A>T (p.Asn81Tyr)	HBB|LOC106099062|LOC107133510	N81Y	not specified	Uncertain significance(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001217240	11	5247881	11	5226651	1217240	1207220		NC_000011.10:5226650:T:A
NM_000518.5(HBB):c.239A>G (p.Asp80Gly)	HBB|LOC106099062|LOC107133510	D80G	HEMOGLOBIN G (HSI-TSOU)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015174	11	5247883	11	5226653	15174	30213	rs34173382	NC_000011.10:5226652:T:C
NM_000518.4(HBB):c.238G>C (p.Asp80His)	LOC107133510|HBB|LOC106099062	D80H	not specified	Uncertain significance(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000015522	11	5247884	11	5226654	15522	30561	rs33990858	NC_000011.10:5226653:C:G
NM_000518.4(HBB):c.238G>T (p.Asp80Tyr)	HBB|LOC106099062|LOC107133510	D80Y	not provided	Likely benign(Last reviewed: Aug 20, 2021)	criteria provided, single submitter	VCV000015371	11	5247884	11	5226654	15371	30410	rs33990858	NC_000011.10:5226653:C:A
NM_000518.4(HBB):c.238G>A (p.Asp80Asn)	LOC107133510|HBB|LOC106099062	D80N	not specified	Uncertain significance(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000015169	11	5247884	11	5226654	15169	30208	rs33990858	NC_000011.10:5226653:C:T
NM_000518.5(HBB):c.236T>G (p.Leu79Arg)	HBB|LOC106099062|LOC107133510	L79R	HEMOGLOBIN QUIN-HAI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015314	11	5247886	11	5226656	15314	30353	rs34870172	NC_000011.10:5226655:A:C
NM_000518.5(HBB):c.233A>G (p.His78Arg)	HBB|LOC106099062|LOC107133510	H78R	HEMOGLOBIN COSTA RICA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015556	11	5247889	11	5226659	15556	30595	rs33952543	NC_000011.10:5226658:T:C
NM_000518.4(HBB):c.232C>G (p.His78Asp)	HBB|LOC106099062|LOC107133510	H78D	not provided	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000015221	11	5247890	11	5226660	15221	30260	rs33991294	NC_000011.10:5226659:G:C
NM_000518.4(HBB):c.232C>T (p.His78Tyr)	HBB|LOC106099062|LOC107133510	H78Y	not specified|not provided	Uncertain significance(Last reviewed: Jul 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015168	11	5247890	11	5226660	15168	30207	rs33991294	NC_000011.10:5226659:G:A
NM_000518.5(HBB):c.230C>A (p.Ala77Asp)	HBB|LOC106099062|LOC107133510	A77D	HEMOGLOBIN J (CHICAGO)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015217	11	5247892	11	5226662	15217	30256	rs33985847	NC_000011.10:5226661:G:T
NM_000518.5(HBB):c.229G>C (p.Ala77Pro)	HBB|LOC106099062|LOC107133510	A77P	HEMOGLOBIN CALAIS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015482	11	5247893	11	5226663	15482	30521	rs35286210	NC_000011.10:5226662:C:G
NM_000518.4(HBB):c.227T>G (p.Leu76Arg)	HBB|LOC106099062|LOC107133510	L76R	HEMOGLOBIN PASADENA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015307	11	5247895	11	5226665	15307	30346	rs33950542	NC_000011.10:5226664:A:C
NM_000518.4(HBB):c.227T>C (p.Leu76Pro)	HBB|LOC106099062|LOC107133510	L76P	HEMOGLOBIN ATLANTA|HEMOGLOBIN ATLANTA-COVENTRY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015100	11	5247895	11	5226665	15100	30139	rs33950542	NC_000011.10:5226664:A:G
NM_000518.4(HBB):c.224G>A (p.Gly75Asp)	HBB|LOC106099062|LOC107133510	G75D	HEMOGLOBIN SHEPHERDS BUSH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015350	11	5247898	11	5226668	15350	30389	rs33976006	NC_000011.10:5226667:C:T
NM_000518.4(HBB):c.224G>T (p.Gly75Val)	HBB|LOC106099062|LOC107133510	G75V	HEMOGLOBIN BUSHWICK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015125	11	5247898	11	5226668	15125	30164	rs33976006	NC_000011.10:5226667:C:A
NM_000518.5(HBB):c.223G>A (p.Gly75Ser)	HBB|LOC106099062|LOC107133510	G75S	not specified|not provided	Uncertain significance(Last reviewed: Dec 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495982	11	5247899	11	5226669	495982	487446	rs33916541	NC_000011.10:5226668:C:T
NM_000518.5(HBB):c.223G>C (p.Gly75Arg)	HBB|LOC106099062|LOC107133510	G75R	HEMOGLOBIN AALBORG	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015089	11	5247899	11	5226669	15089	30128	rs33916541	NC_000011.10:5226668:C:G
NM_000518.4(HBB):c.221A>G (p.Asp74Gly)	HBB|LOC106099062|LOC107133510	D74G	HEMOGLOBIN TILBURG	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015373	11	5247901	11	5226671	15373	30412	rs33967755	NC_000011.10:5226670:T:C
NM_000518.4(HBB):c.221A>T (p.Asp74Val)	HBB|LOC106099062|LOC107133510	D74V	HEMOGLOBIN MOBILE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015273	11	5247901	11	5226671	15273	30312	rs33967755	NC_000011.10:5226670:T:A
NM_000518.5(HBB):c.220G>C (p.Asp74His)	HBB|LOC106099062|LOC107133510	D74H	not provided	Uncertain significance(Last reviewed: Mar 15, 2021)	criteria provided, single submitter	VCV001330628	11	5247902	11	5226672	1330628	1321307		NC_000011.10:5226671:C:G
NM_000518.4(HBB):c.[20A>T;220G>A]	HBB|LOC106099062|LOC107133510	D74N, E7V	HEMOGLOBIN ZIGUINCHOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446730	11|11	5247902	11|11	5226672	446730	30283|30372	rs33945705|rs334	NC_000011.10:5226671:C:T|NC_000011.10:5227001:T:A
NM_000518.4(HBB):c.220G>T (p.Asp74Tyr)	HBB|LOC106099062|LOC107133510	D74Y	HEMOGLOBIN VANCOUVER	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015382	11	5247902	11	5226672	15382	30421	rs33945705	NC_000011.10:5226671:C:A
NM_000518.4(HBB):c.220G>A (p.Asp74Asn)	HBB|LOC106099062|LOC107133510	D74N	not specified|not provided	Likely benign(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015244	11	5247902	11	5226672	15244	30283	rs33945705	NC_000011.10:5226671:C:T
NM_000518.5(HBB):c.216T>A (p.Phe72Leu)	LOC106099062|LOC107133510|HBB	F72L	not provided	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000801185	11	5247906	11	5226676	801185	789499	rs754481448	NC_000011.10:5226675:A:T
NM_000518.5(HBB):c.215T>C (p.Phe72Ser)	HBB|LOC106099062|LOC107133510	F72S	HEMOGLOBIN CHRISTCHURCH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015137	11	5247907	11	5226677	15137	30176	rs34362537	NC_000011.10:5226676:A:G
NM_000518.4(HBB):c.212C>T (p.Ala71Val)	HBB|LOC106099062|LOC107133510	A71V	HEMOGLOBIN MARINEO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015621	11	5247910	11	5226680	15621	30660	rs33946401	NC_000011.10:5226679:G:A
NM_000518.4(HBB):c.212C>A (p.Ala71Asp)	HBB|LOC106099062|LOC107133510	A71D	HEMOGLOBIN SEATTLE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015346	11	5247910	11	5226680	15346	30385	rs33946401	NC_000011.10:5226679:G:T
NM_000518.5(HBB):c.209G>A (p.Gly70Asp)	HBB|LOC106099062|LOC107133510	G70D	not provided	Likely benign(Last reviewed: Jan 10, 2022)	criteria provided, single submitter	VCV000015226	11	5247913	11	5226683	15226	30265	rs34718174	NC_000011.10:5226682:C:T
NM_000518.4(HBB):c.208G>C (p.Gly70Arg)	HBB|LOC106099062|LOC107133510	G70R	HEMOGLOBIN KENITRA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015237	11	5247914	11	5226684	15237	30276	rs33947415	NC_000011.10:5226683:C:G
NM_000518.4(HBB):c.208G>A (p.Gly70Ser)	LOC106099062|LOC107133510|HBB	G70S	Hb SS disease|Erythrocytosis, familial, 6|Methemoglobinemia, beta-globin type|beta Thalassemia|Malaria, susceptibility to|Heinz body anemia|Dominant beta-thalassemia|alpha Thalassemia|Fetal hemoglobin quantitative trait locus 1|not specified|not provided|Fetal hemoglobin quantitative trait locus 1|beta Thalassemia|Hemoglobin E|Hb SS disease	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2023)	criteria provided, conflicting interpretations	VCV000015138	11	5247914	11	5226684	15138	30177	rs33947415	NC_000011.10:5226683:C:T
NM_000518.4(HBB):c.206T>C (p.Leu69Pro)	HBB|LOC106099062|LOC107133510	L69P	HEMOGLOBIN MIZUHO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015271	11	5247916	11	5226686	15271	30310	rs33972593	NC_000011.10:5226685:A:G
NM_000518.4(HBB):c.206T>A (p.Leu69His)	HBB|LOC106099062|LOC107133510	L69H	Erythrocytosis, familial, 6|HEMOGLOBIN BRISBANE|HEMOGLOBIN GREAT LAKES	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015117	11	5247916	11	5226686	15117	30156	rs33972593	NC_000011.10:5226685:A:T
NM_000518.5(HBB):c.205C>T (p.Leu69Phe)	HBB|LOC106099062|LOC107133510	L69F	not provided|Beta-thalassemia HBB/LCRB|Hb SS disease|Hereditary persistence of fetal hemoglobin|Methemoglobinemia, beta-globin type|alpha Thalassemia|Heinz body anemia|Erythrocytosis, familial, 6|Dominant beta-thalassemia|Malaria, susceptibility to	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015613	11	5247917	11	5226687	15613	30652	rs33961459	NC_000011.10:5226686:G:A
NM_000518.4(HBB):c.203T>G (p.Val68Gly)	HBB|LOC106099062|LOC107133510	V68G	not provided	Uncertain significance(Last reviewed: Jun 2, 2022)	criteria provided, single submitter	VCV000015527	11	5247919	11	5226689	15527	30566	rs33918343	NC_000011.10:5226688:A:C
NM_000518.4(HBB):c.203T>C (p.Val68Ala)	HBB|LOC106099062|LOC107133510	V68A	HEMOGLOBIN SYDNEY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015364	11	5247919	11	5226689	15364	30403	rs33918343	NC_000011.10:5226688:A:G
NM_000518.4(HBB):c.203T>A (p.Val68Glu)	HBB|LOC106099062|LOC107133510	V68E	HEMOGLOBIN M (MILWAUKEE 1)|Methemoglobinemia, beta-globin type	Pathogenic; other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015254	11	5247919	11	5226689	15254	30293	rs33918343	NC_000011.10:5226688:A:T
NM_000518.4(HBB):c.202G>A (p.Val68Met)	HBB|LOC106099062|LOC107133510	V68M	HEMOGLOBIN ALESHA|HEMOGLOBIN BRISTOL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015536	11	5247920	11	5226690	15536	30575	rs36008922	NC_000011.10:5226689:C:T
NM_000518.5(HBB):c.200A>C (p.Lys67Thr)	HBB|LOC106099062|LOC107133510	K67T	not provided	Likely pathogenic(Last reviewed: May 18, 2021)	criteria provided, single submitter	VCV000015136	11	5247922	11	5226692	15136	30175	rs35939489	NC_000011.10:5226691:T:G
NM_000518.5(HBB):c.199A>G (p.Lys67Glu)	HBB|LOC106099062|LOC107133510	K67E	not provided	Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000015206	11	5247923	11	5226693	15206	30245	rs34165323	NC_000011.10:5226692:T:C
NM_000518.5(HBB):c.198G>C (p.Lys66Asn)	HBB|LOC106099062|LOC107133510	K66N	HEMOGLOBIN J (SICILIA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015227	11	5247924	11	5226694	15227	30266	rs35747961	NC_000011.10:5226693:C:G
NM_000518.4(HBB):c.[197A>T;367T>C]	LOC106099062|HBB|LOC107133510|LOC110006319	K66M, F123L	HEMOGLOBIN CASABLANCA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446744	11|11	5247925	11|11	5226695	446744	30250|30619	rs33932548|rs33971848	NC_000011.10:5226694:T:A|NC_000011.10:5225674:A:G
NM_000518.5(HBB):c.197A>T (p.Lys66Met)	HBB|LOC106099062|LOC107133510	K66M	HEMOGLOBIN J (ANTAKYA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015211	11	5247925	11	5226695	15211	30250	rs33932548	NC_000011.10:5226694:T:A
NM_000518.5(HBB):c.196A>C (p.Lys66Gln)	HBB|LOC106099062|LOC107133510	K66Q	HEMOGLOBIN J (CAIRO)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015215	11	5247926	11	5226696	15215	30254	rs35353749	NC_000011.10:5226695:T:G
NM_000518.4(HBB):c.194G>C (p.Gly65Ala)	HBB|LOC106099062|LOC107133510	G65A	not provided	Uncertain significance(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000015599	11	5247928	11	5226698	15599	30638	rs33922018	NC_000011.10:5226697:C:G
NM_000518.4(HBB):c.194G>A (p.Gly65Asp)	HBB|LOC106099062|LOC107133510	G65D	HEMOGLOBIN J (CALABRIA)|HEMOGLOBIN J (COSENZA)|HEMOGLOBIN J (BARI)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015216	11	5247928	11	5226698	15216	30255	rs33922018	NC_000011.10:5226697:C:T
NM_000518.4(HBB):c.191A>G (p.His64Arg)	HBB|LOC106099062|LOC107133510	H64R	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2022)	criteria provided, conflicting interpretations	VCV000015400	11	5247931	11	5226701	15400	30439	rs33985544	NC_000011.10:5226700:T:C
NM_000518.4(HBB):c.191A>C (p.His64Pro)	HBB|LOC107133510|LOC106099062	H64P	HEMOGLOBIN BICETRE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015113	11	5247931	11	5226701	15113	30152	rs33985544	NC_000011.10:5226700:T:G
NM_000518.5(HBB):c.190C>A (p.His64Asn)	LOC106099062|LOC107133510|HBB	H64N	HEMOGLOBIN HANA	Pathogenic(Last reviewed: Nov 14, 2019)	no assertion criteria provided	VCV000694445	11	5247932	11	5226702	694445	682369		NC_000011.10:5226701:G:T
NM_000518.5(HBB):c.190C>T (p.His64Tyr)	HBB|LOC106099062|LOC107133510	H64Y	Inborn genetic diseases|beta Thalassemia	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015256	11	5247932	11	5226702	15256	30295	rs33922873	NC_000011.10:5226701:G:A
NM_000518.5(HBB):c.188C>A (p.Ala63Asp)	HBB|LOC106099062|LOC107133510	A63D	HEMOGLOBIN J (EUROPA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015553	11	5247934	11	5226704	15553	30592	rs34151786	NC_000011.10:5226703:G:T
NM_000518.5(HBB):c.187G>C (p.Ala63Pro)	LOC106099062|LOC107133510|HBB	A63P	HEMOGLOBIN DUARTE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015160	11	5247935	11	5226705	15160	30199	rs34933455	NC_000011.10:5226704:C:G
NM_000518.5(HBB):c.186G>C (p.Lys62Asn)	HBB|LOC106099062|LOC107133510	K62N	not provided	Likely benign(Last reviewed: Mar 15, 2022)	criteria provided, single submitter	VCV000015196	11	5247936	11	5226706	15196	30235	rs34446260	NC_000011.10:5226705:C:G
NM_000518.5(HBB):c.185A>T (p.Lys62Met)	HBB|LOC106099062|LOC107133510	K62M	HEMOGLOBIN BOLOGNA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015114	11	5247937	11	5226707	15114	30153	rs34974709	NC_000011.10:5226706:T:A
NM_000518.4(HBB):c.184A>C (p.Lys62Gln)	HBB|LOC106099062|LOC107133510	K62Q	HEMOGLOBIN POCOS DE CALDAS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015603	11	5247938	11	5226708	15603	30642	rs33995148	NC_000011.10:5226707:T:G
NM_000518.4(HBB):c.184A>G (p.Lys62Glu)	HBB|LOC106099062|LOC107133510	K62E	not provided	Uncertain significance(Last reviewed: Nov 18, 2021)	criteria provided, single submitter	VCV000015280	11	5247938	11	5226708	15280	30319	rs33995148	NC_000011.10:5226707:T:C
NM_000518.4(HBB):c.182T>A (p.Val61Glu)	HBB|LOC106099062|LOC107133510	V61E	Beta-plus-thalassemia|HEMOGLOBIN CAGLIARI	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015411	11	5247940	11	5226710	15411	30450	rs33931779	NC_000011.10:5226709:A:T
NM_000518.4(HBB):c.182T>C (p.Val61Ala)	HBB|LOC106099062|LOC107133510	V61A	HEMOGLOBIN COLLINGWOOD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015141	11	5247940	11	5226710	15141	30180	rs33931779	NC_000011.10:5226709:A:G
NM_000518.5(HBB):c.181G>C (p.Val61Leu)	HBB|LOC106099062|LOC107133510	V61L	HEMOGLOBIN YATSUSHIRO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015393	11	5247941	11	5226711	15393	30432	rs33990253	NC_000011.10:5226710:C:G
NM_000518.5(HBB):c.180G>C (p.Lys60Asn)	LOC107133510|LOC106099062|HBB	K60N	not specified|not provided	Uncertain significance(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015224	11	5247942	11	5226712	15224	30263	rs34621955	NC_000011.10:5226711:C:G
NM_000518.5(HBB):c.179A>C (p.Lys60Thr)	HBB|LOC106099062|LOC107133510	K60T	not provided	Uncertain significance(Last reviewed: Dec 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015222	11	5247943	11	5226713	15222	30261	rs35537181	NC_000011.10:5226712:T:G
NM_000518.5(HBB):c.178A>G (p.Lys60Glu)	HBB|LOC106099062|LOC107133510	K60E	HEMOGLOBIN I (HIGH WYCOMBE)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015205	11	5247944	11	5226714	15205	30244	rs33969400	NC_000011.10:5226713:T:C
NM_000518.5(HBB):c.176C>G (p.Pro59Arg)	HBB|LOC106099062|LOC107133510	P59R	not specified	Uncertain significance(Last reviewed: Mar 3, 2022)	criteria provided, single submitter	VCV000015398	11	5247946	11	5226716	15398	30437	rs33991472	NC_000011.10:5226715:G:C
NM_000518.5(HBB):c.174C>A (p.Asn58Lys)	HBB|LOC106099062|LOC107133510	N58K	not provided	Uncertain significance(Last reviewed: Oct 1, 2021)	criteria provided, single submitter	VCV000015172	11	5247948	11	5226718	15172	30211	rs35278874	NC_000011.10:5226717:G:T
NM_000518.5(HBB):c.173A>G (p.Asn58Ser)	HBB|LOC106099062|LOC107133510	N58S	not provided	Uncertain significance(Last reviewed: Jun 26, 2021)	criteria provided, single submitter	VCV001050399	11	5247949	11	5226719	1050399	1038069		NC_000011.10:5226718:T:C
NM_000518.5(HBB):c.172A>G (p.Asn58Asp)	HBB|LOC106099062|LOC107133510	N58D	HEMOGLOBIN J (DALOA)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015219	11	5247950	11	5226720	15219	30258	rs33988732	NC_000011.10:5226719:T:C
NM_000518.5(HBB):c.170G>A (p.Gly57Asp)	HBB|LOC106099062|LOC107133510	G57D	not provided	Likely benign(Last reviewed: Jul 8, 2021)	criteria provided, single submitter	VCV000015214	11	5247952	11	5226722	15214	30253	rs34439278	NC_000011.10:5226721:C:T
NM_000518.5(HBB):c.169G>A (p.Gly57Ser)	LOC107133510|LOC106099062|HBB	G57S	not specified|Malaria, susceptibility to|Dominant beta-thalassemia|Erythrocytosis, familial, 6|Heinz body anemia|alpha Thalassemia|Methemoglobinemia, beta-globin type|Hb SS disease|Hereditary persistence of fetal hemoglobin|Beta-thalassemia HBB/LCRB|not provided	Uncertain significance(Last reviewed: Aug 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000619854	11	5247953	11	5226723	619854	611099	rs33935983	NC_000011.10:5226722:C:T
NM_000518.4(HBB):c.[169G>C;259G>C]	HBB|LOC106099062|LOC107133510	G57R, A87P	HEMOGLOBIN POISSY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446734	11|11	5247953	11|11	5226723	446734	30227|30650	rs33935983|rs33952147	NC_000011.10:5226722:C:G|NC_000011.10:5226632:C:G
NM_000518.5(HBB):c.169G>C (p.Gly57Arg)	HBB|LOC106099062|LOC107133510	G57R	HEMOGLOBIN HAMADAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015188	11	5247953	11	5226723	15188	30227	rs33935983	NC_000011.10:5226722:C:G
NM_000518.5(HBB):c.167T>C (p.Met56Thr)	HBB|LOC106099062|LOC107133510	M56T	not specified	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000928761	11	5247955	11	5226725	928761	917087	rs35094013	NC_000011.10:5226724:A:G
NM_000518.5(HBB):c.167T>A (p.Met56Lys)	HBB|LOC106099062|LOC107133510	M56K	HEMOGLOBIN MATERA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015263	11	5247955	11	5226725	15263	30302	rs35094013	NC_000011.10:5226724:A:T
NM_000518.5(HBB):c.164T>C (p.Val55Ala)	HBB|LOC106099062|LOC107133510	V55A	not specified	Uncertain significance(Last reviewed: Apr 6, 2022)	criteria provided, single submitter	VCV001683259	11	5247958	11	5226728	1683259	1675158		NC_000011.10:5226727:A:G
NM_000518.5(HBB):c.164T>A (p.Val55Asp)	HBB|LOC106099062|LOC107133510	V55D	HEMOGLOBIN JACKSONVILLE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015490	11	5247958	11	5226728	15490	30529	rs34037627	NC_000011.10:5226727:A:T
NM_000518.5(HBB):c.158A>T (p.Asp53Val)	LOC107133510|LOC106099062|HBB	D53V	not provided	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000618676	11	5247964	11	5226734	618676	609792	rs33919924	NC_000011.10:5226733:T:A
NM_000518.4(HBB):c.158A>G (p.Asp53Gly)	HBB|LOC106099062|LOC107133510	D53G	HEMOGLOBIN HOKUSETSU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015559	11	5247964	11	5226734	15559	30598	rs33919924	NC_000011.10:5226733:T:C
NM_000518.4(HBB):c.158A>C (p.Asp53Ala)	HBB|LOC106099062|LOC107133510	D53A	HEMOGLOBIN OCHO RIOS	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015293	11	5247964	11	5226734	15293	30332	rs33919924	NC_000011.10:5226733:T:G
NM_000518.4(HBB):c.[154C>T;157G>A]	HBB|LOC106099062|LOC107133510	D53N, P52S	HEMOGLOBIN GRENOBLE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446741	11|11	5247965	11|11	5226735	446741	30341|30536	rs33961886|rs281864894	NC_000011.10:5226734:C:T|NC_000011.10:5226737:G:A
NM_000518.4(HBB):c.157G>C (p.Asp53His)	LOC106099062|HBB|LOC107133510	D53H	not specified|not provided	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015362	11	5247965	11	5226735	15362	30401	rs33961886	NC_000011.10:5226734:C:G
NM_000518.4(HBB):c.157G>A (p.Asp53Asn)	HBB|LOC106099062|LOC107133510	D53N	not specified|not provided|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: May 26, 2022)	criteria provided, conflicting interpretations	VCV000015302	11	5247965	11	5226735	15302	30341	rs33961886	NC_000011.10:5226734:C:T
NM_000518.5(HBB):c.155C>G (p.Pro52Arg)	HBB|LOC106099062|LOC107133510	P52R	HEMOGLOBIN WILLAMETTE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015377	11	5247967	11	5226737	15377	30416	rs33969727	NC_000011.10:5226736:G:C
NM_000518.5(HBB):c.154C>A (p.Pro52Thr)	LOC107133510|HBB|LOC106099062	P52T	not provided	Uncertain significance(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000993225	11	5247968	11	5226738	993225	981063	rs281864894	NC_000011.10:5226737:G:T
NM_000518.5(HBB):c.154C>T (p.Pro52Ser)	HBB|LOC106099062|LOC107133510	P52S		no interpretation for the single variant	no interpretation for the single variant	VCV000478834	11	5247968	11	5226738	478834	30536	rs281864894	NC_000011.10:5226737:G:A
NM_000518.5(HBB):c.152_153delinsAR (p.Thr51Lys)	HBB|LOC106099062|LOC107133510	T51K	HEMOGLOBIN EDMONTON	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015163	11	5247969 - 5247970	11	5226739 - 5226740	15163	30202		NC_000011.10:5226738:AG:YT
NM_000518.5(HBB):c.151A>T (p.Thr51Ser)	HBB|LOC106099062|LOC107133510	T51S	not specified	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000495980	11	5247971	11	5226741	495980	487504	rs63750336	NC_000011.10:5226740:T:A
NM_000518.4(HBB):c.149C>G (p.Ser50Cys)	HBB|LOC106099062|LOC107133510	S50C	HEMOGLOBIN COLIMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015602	11	5247973	11	5226743	15602	30641	rs33960931	NC_000011.10:5226742:G:C
NM_000518.4(HBB):c.149C>T (p.Ser50Phe)	HBB|LOC106099062|LOC107133510	S50F	not specified	Uncertain significance(Last reviewed: Dec 30, 2021)	criteria provided, single submitter	VCV000015246	11	5247973	11	5226743	15246	30285	rs33960931	NC_000011.10:5226742:G:A
NM_000518.4(HBB):c.146T>C (p.Leu49Pro)	HBB|LOC106099062|LOC107133510	L49P	HEMOGLOBIN BAB-SAADOUN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015510	11	5247976	11	5226746	15510	30549	rs33952850	NC_000011.10:5226745:A:G
NM_000518.4(HBB):c.146T>G (p.Leu49Arg)	HBB|LOC106099062|LOC107133510	L49R	HEMOGLOBIN OKALOOSA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015295	11	5247976	11	5226746	15295	30334	rs33952850	NC_000011.10:5226745:A:C
NM_000518.5(HBB):c.144T>A (p.Asp48Glu)	HBB|LOC106099062|LOC107133510	D48E	not provided	Uncertain significance(Last reviewed: May 19, 2020)	criteria provided, single submitter	VCV000993533	11	5247978	11	5226748	993533	981744	rs754454495	NC_000011.10:5226747:A:T
NM_000518.4(HBB):c.143A>G (p.Asp48Gly)	HBB|LOC106099062|LOC107133510	D48G	HEMOGLOBIN GAVELLO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015181	11	5247979	11	5226749	15181	30220	rs33980484	NC_000011.10:5226748:T:C
NM_000518.4(HBB):c.143A>C (p.Asp48Ala)	HBB|LOC106099062|LOC107133510	D48A	HEMOGLOBIN AVICENNA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015103	11	5247979	11	5226749	15103	30142	rs33980484	NC_000011.10:5226748:T:G
NM_000518.4(HBB):c.142G>T (p.Asp48Tyr)	HBB|LOC106099062|LOC107133510	D48Y	HEMOGLOBIN MAPUTO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015260	11	5247980	11	5226750	15260	30299	rs33932070	NC_000011.10:5226749:C:A
NM_000518.4(HBB):c.142G>A (p.Asp48Asn)	HBB|LOC106099062|LOC107133510	D48N	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 19, 2021)	criteria provided, conflicting interpretations	VCV000015170	11	5247980	11	5226750	15170	30209	rs33932070	NC_000011.10:5226749:C:T
NM_000518.5(HBB):c.140G>A (p.Gly47Glu)	HBB|LOC106099062|LOC107133510	G47E	not provided	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000015232	11	5247982	11	5226752	15232	30271	rs35303218	NC_000011.10:5226751:C:T
NM_000518.5(HBB):c.139G>C (p.Gly47Arg)	LOC106099062|LOC107133510|HBB	G47R	not provided	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV000993224	11	5247983	11	5226753	993224	981064	rs34743882	NC_000011.10:5226752:C:G
NM_000518.5(HBB):c.139G>A (p.Gly47Arg)	HBB|LOC106099062|LOC107133510	G47R	HEMOGLOBIN GAINESVILLE-GA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015180	11	5247983	11	5226753	15180	30219	rs34743882	NC_000011.10:5226752:C:T
NM_000518.4(HBB):c.137T>G (p.Phe46Cys)	HBB|LOC106099062|LOC107133510	F46C	HEMOGLOBIN ARTA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015546	11	5247985	11	5226755	15546	30585	rs33978338	NC_000011.10:5226754:A:C
NM_000518.4(HBB):c.137T>C (p.Phe46Ser)	HBB|LOC106099062|LOC107133510	F46S	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2023)	criteria provided, conflicting interpretations	VCV000015135	11	5247985	11	5226755	15135	30174	rs33978338	NC_000011.10:5226754:A:G
NM_000518.5(HBB):c.134C>G (p.Ser45Cys)	HBB|LOC106099062|LOC107133510	S45C	not provided	Uncertain significance(Last reviewed: Jun 9, 2021)	criteria provided, single submitter	VCV000015267	11	5247988	11	5226758	15267	30306	rs34868397	NC_000011.10:5226757:G:C
NM_000518.5(HBB):c.131A>G (p.Glu44Gly)	LOC106099062|LOC107133510|HBB	E44G	not provided	Uncertain significance(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000619853	11	5247991	11	5226761	619853	611100	rs35262412	NC_000011.10:5226760:T:C
NM_000518.5(HBB):c.131A>C (p.Glu44Ala)	HBB|LOC106099062|LOC107133510	E44A	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)	criteria provided, conflicting interpretations	VCV000015173	11	5247991	11	5226761	15173	30212	rs35262412	NC_000011.10:5226760:T:G
NM_000518.4(HBB):c.130G>C (p.Glu44Gln)	HBB|LOC106099062|LOC107133510	E44Q	not specified	Benign(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015203	11	5247992	11	5226762	15203	30242	rs33922842	NC_000011.10:5226761:C:G
NM_000518.5(HBB):c.128T>C (p.Phe43Ser)	HBB|LOC106099062|LOC107133510	F43S	not provided	Pathogenic(Last reviewed: Mar 25, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015190	11	5247994	11	5226764	15190	30229	rs34378160	NC_000011.10:5226763:A:G
NM_000518.4(HBB):c.127T>G (p.Phe43Val)	HBB|LOC106099062|LOC107133510	F43V	Hemolytic anemia	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000015347	11	5247995	11	5226765	15347	30386	rs33924146	NC_000011.10:5226764:A:C
NM_000518.5(HBB):c.127T>C (p.Phe43Leu)	HBB|LOC106099062|LOC107133510	F43L	Hemolytic anemia	Pathogenic(Last reviewed: Jan 1, 1989)	no assertion criteria provided	VCV000015251	11	5247995	11	5226765	15251	30290	rs33924146	NC_000011.10:5226764:A:G
NM_000518.4(HBB):c.125T>G (p.Phe42Cys)	HBB|LOC106099062|LOC107133510	F42C	HEMOGLOBIN ILMENAU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015598	11	5247997	11	5226767	15598	30637	rs33926796	NC_000011.10:5226766:A:C
NM_000518.4(HBB):c.125T>C (p.Phe42Ser)	HBB|LOC106099062|LOC107133510	F42S	not provided	Uncertain significance(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000015530	11	5247997	11	5226767	15530	30569	rs33926796	NC_000011.10:5226766:A:G
NM_000518.4(HBB):c.125T>A (p.Phe42Tyr)	HBB|LOC106099062|LOC107133510	F42Y	HEMOGLOBIN MEQUON	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015264	11	5247997	11	5226767	15264	30303	rs33926796	NC_000011.10:5226766:A:T
NM_000518.5(HBB):c.123G>T (p.Arg41Ser)	LOC107133510|HBB|LOC106099062	R41S	not provided|Hb SS disease|Malaria, susceptibility to|alpha Thalassemia|Dominant beta-thalassemia|Hereditary persistence of fetal hemoglobin|Beta-thalassemia HBB/LCRB|Erythrocytosis, familial, 6|Heinz body anemia|Methemoglobinemia, beta-globin type	Uncertain significance(Last reviewed: Aug 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439134	11	5247999	11	5226769	439134	432692	rs33918778	NC_000011.10:5226768:C:A
NM_000518.5(HBB):c.123G>C (p.Arg41Ser)	HBB|LOC106099062|LOC107133510	R41S	HEMOGLOBIN AUSTIN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015102	11	5247999	11	5226769	15102	30141	rs33918778	NC_000011.10:5226768:C:G
NM_000518.5(HBB):c.122G>A (p.Arg41Lys)	HBB|LOC106099062|LOC107133510	R41K	not specified|not provided	Likely benign(Last reviewed: May 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015099	11	5248000	11	5226770	15099	30138	rs34831026	NC_000011.10:5226769:C:T
NM_000518.5(HBB):c.120G>C (p.Gln40His)	LOC106099062|LOC107133510|HBB	Q40H	not provided	Uncertain significance(Last reviewed: Nov 18, 2018)	criteria provided, single submitter	VCV000801183	11	5248002	11	5226772	801183	789500	rs34663314	NC_000011.10:5226771:C:G
NM_000518.5(HBB):c.119A>G (p.Gln40Arg)	HBB|LOC106099062|LOC107133510	Q40R	HEMOGLOBIN TIANSHUI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015372	11	5248003	11	5226773	15372	30411	rs35973315	NC_000011.10:5226772:T:C
NM_000518.5(HBB):c.118C>A (p.Gln40Lys)	LOC107133510|HBB|LOC106099062	Q40K	not provided	Uncertain significance(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV000811501	11	5248004	11	5226774	811501	799653	rs11549407	NC_000011.10:5226773:G:T
NM_000518.5(HBB):c.118C>G (p.Gln40Glu)	HBB|LOC106099062|LOC107133510	Q40E	HEMOGLOBIN VAASA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015381	11	5248004	11	5226774	15381	30420		NC_000011.10:5226773:G:C
NM_000518.5(HBB):c.116C>T (p.Thr39Ile)	HBB|LOC106099062|LOC107133510	T39I	HEMOGLOBIN LA CORUNA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015622	11	5248006	11	5226776	15622	30661	rs34703513	NC_000011.10:5226775:G:A
NM_000518.5(HBB):c.116C>A (p.Thr39Asn)	HBB|LOC106099062|LOC107133510	T39N	HEMOGLOBIN HINWIL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015549	11	5248006	11	5226776	15549	30588	rs34703513	NC_000011.10:5226775:G:T
NM_000518.5(HBB):c.115A>C (p.Thr39Pro)	HBB|LOC106099062|LOC107133510	T39P	HEMOGLOBIN HAZEBROUCK	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015191	11	5248007	11	5226777	15191	30230	rs34571024	NC_000011.10:5226776:T:G
NM_000518.5(HBB):c.113G>C (p.Trp38Ser)	HBB|LOC106099062|LOC107133510	W38S	HEMOGLOBIN HIROSE	other(Last reviewed: Aug 3, 2021)	no assertion criteria provided	VCV000015199	11	5248009	11	5226779	15199	30238	rs33991059	NC_000011.10:5226778:C:G
NM_000518.5(HBB):c.112T>G (p.Trp38Gly)	HBB|LOC106099062|LOC107133510	W38G	HEMOGLOBIN HOWICK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015529	11	5248010	11	5226780	15529	30568	rs33994623	NC_000011.10:5226779:A:C
NM_000518.5(HBB):c.112T>A (p.Trp38Arg)	HBB|LOC106099062|LOC107133510	W38R	HEMOGLOBIN ROTHSCHILD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015331	11	5248010	11	5226780	15331	30370	rs33994623	NC_000011.10:5226779:A:T
NM_000518.4(HBB):c.110C>A (p.Pro37His)	HBB|LOC106099062|LOC107133510	P37H	Erythrocytosis, familial, 6	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000015578	11	5248012	11	5226782	15578	30617	rs33993004	NC_000011.10:5226781:G:T
NM_000518.4(HBB):c.110C>G (p.Pro37Arg)	HBB|LOC106099062|LOC107133510	P37R	HEMOGLOBIN SUNNYBROOK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015363	11	5248012	11	5226782	15363	30402	rs33993004	NC_000011.10:5226781:G:C
NM_000518.4(HBB):c.109C>G (p.Pro37Ala)	HBB|LOC106099062|LOC107133510	P37A	HEMOGLOBIN BRIE COMTE ROBERT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015575	11	5248013	11	5226783	15575	30614	rs33948615	NC_000011.10:5226782:G:C
NM_000518.4(HBB):c.109C>T (p.Pro37Ser)	HBB|LOC106099062|LOC107133510	P37S	HEMOGLOBIN NORTH CHICAGO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015289	11	5248013	11	5226783	15289	30328	rs33948615	NC_000011.10:5226782:G:A
NM_000518.4(HBB):c.109C>A (p.Pro37Thr)	HBB|LOC106099062|LOC107133510	P37T	HEMOGLOBIN LINKOPING|HEMOGLOBIN MEILAHTI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015249	11	5248013	11	5226783	15249	30288	rs33948615	NC_000011.10:5226782:G:T
NM_000518.5(HBB):c.107A>G (p.Tyr36Cys)	HBB|LOC106099062|LOC107133510	Y36C	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869262	11	5248015	11	5226785	869262	857492	rs35857380	NC_000011.10:5226784:T:C
NM_000518.5(HBB):c.107A>T (p.Tyr36Phe)	HBB|LOC106099062|LOC107133510	Y36F	HEMOGLOBIN PHILLY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015310	11	5248015	11	5226785	15310	30349	rs35857380	NC_000011.10:5226784:T:A
NM_000518.5(HBB):c.104T>A (p.Val35Asp)	HBB|LOC106099062|LOC107133510	V35D	HEMOGLOBIN SANTANDER	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015605	11	5248018	11	5226788	15605	30644	rs1135101	NC_000011.10:5226787:A:T
NM_000518.5(HBB):c.103G>T (p.Val35Phe)	HBB|LOC106099062|LOC107133510	V35F	not provided	Likely pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000015312	11	5248019	11	5226789	15312	30351	rs1141387	NC_000011.10:5226788:C:A
NM_000518.5(HBB):c.100G>A (p.Val34Met)	HBB|LOC106099062|LOC107133510	V34M	not specified	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000015566	11	5248022	11	5226792	15566	30605	rs1141370	NC_000011.10:5226791:C:T
NM_000518.4(HBB):c.98T>A (p.Leu33Gln)	LOC106099062|LOC107133510|HBB	L33Q	not provided	Likely pathogenic(Last reviewed: May 19, 2020)	criteria provided, single submitter	VCV000478852	11	5248024	11	5226794	478852	30572	rs33948578	NC_000011.10:5226793:A:T
NM_000518.4(HBB):c.98T>C (p.Leu33Pro)	HBB|LOC106099062|LOC107133510	L33P	HEMOGLOBIN PERTH|HEMOGLOBIN ABRAHAM LINCOLN|HEMOGLOBIN KOBE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015308	11	5248024	11	5226794	15308	30347	rs33948578	NC_000011.10:5226793:A:G
NM_000518.4(HBB):c.98T>G (p.Leu33Arg)	HBB|LOC106099062|LOC107133510	L33R	HEMOGLOBIN CASTILLA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015132	11	5248024	11	5226794	15132	30171	rs33948578	NC_000011.10:5226793:A:C
NM_000518.5(HBB):c.95T>G (p.Leu32Arg)	HBB|LOC106099062|LOC107133510	L32R	HEMOGLOBIN HAKKARI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015544	11	5248027	11	5226797	15544	30583	rs33920173	NC_000011.10:5226796:A:C
NM_000518.4(HBB):c.95T>C (p.Leu32Pro)	HBB|LOC106099062|LOC107133510	L32P	HEMOGLOBIN YOKOHAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015394	11	5248027	11	5226797	15394	30433	rs33920173	NC_000011.10:5226796:A:G
NM_000518.5(HBB):c.94C>G (p.Leu32Val)	HBB|LOC106099062|LOC107133510	L32V	HEMOGLOBIN MUSCAT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015509	11	5248028	11	5226798	15509	30548	rs33956555	NC_000011.10:5226797:G:C
NM_000518.5(HBB):c.93G>C (p.Arg31Ser)	HBB|LOC106099062|LOC107133510	R31S	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869321	11	5248029	11	5226799	869321	857494	rs1135071	NC_000011.10:5226798:C:G
NM_000518.5(HBB):c.93G>T (p.Arg31Ser)	HBB|LOC106099062|LOC107133510	R31S	Beta-thalassemia HBB/LCRB|not specified|not provided	Uncertain significance(Last reviewed: Mar 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015368	11	5248029	11	5226799	15368	30407	rs1135071	NC_000011.10:5226798:C:A
NM_000518.5(HBB):c.92G>A (p.Arg31Lys)	LOC107133510|HBB|LOC106099062	R31K	not provided|beta Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000036337	11	5248160	11	5226930	36337	45001	rs33960103	NC_000011.10:5226929:C:T
NM_000518.4(HBB):c.92G>C (p.Arg31Thr)	HBB|LOC106099062|LOC107133510	R31T	not provided|Beta-thalassemia major|beta Thalassemia|Hb SS disease	Pathogenic(Last reviewed: Oct 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015234	11	5248160	11	5226930	15234	30273	rs33960103	NC_000011.10:5226929:C:G
NM_000518.5(HBB):c.91A>G (p.Arg31Gly)	LOC106099062|LOC107133510|HBB	R31G	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869243	11	5248161	11	5226931	869243	857496	rs35684407	NC_000011.10:5226930:T:C
NM_000518.5(HBB):c.89G>A (p.Gly30Asp)	HBB|LOC106099062|LOC107133510	G30D	HEMOGLOBIN LUFKIN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015252	11	5248163	11	5226933	15252	30291	rs35685286	NC_000011.10:5226932:C:T
NM_000518.5(HBB):c.88G>A (p.Gly30Ser)	HBB|LOC106099062|LOC107133510	G30S	HEMOGLOBIN TIZI-OUZOU	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015615	11	5248164	11	5226934	15615	30654	rs33974277	NC_000011.10:5226933:C:T
NM_000518.4(HBB):c.86T>G (p.Leu29Arg)	HBB|LOC106099062|LOC107133510	L29R	HEMOGLOBIN CHESTERFIELD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015491	11	5248166	11	5226936	15491	30530	rs33916412	NC_000011.10:5226935:A:C
NM_000518.4(HBB):c.86T>A (p.Leu29Gln)	HBB|LOC106099062|LOC107133510	L29Q	HEMOGLOBIN ST. LOUIS|Heinz body anemia	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015361	11	5248166	11	5226936	15361	30400	rs33916412	NC_000011.10:5226935:A:T
NM_000518.4(HBB):c.86T>C (p.Leu29Pro)	HBB|LOC106099062|LOC107133510	L29P	Hemoglobinopathy	Pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV000015183	11	5248166	11	5226936	15183	30222	rs33916412	NC_000011.10:5226935:A:G
NM_000518.5(HBB):c.85C>A (p.Leu29Met)	HBB|LOC106099062|LOC107133510	L29M	HEMOGLOBIN CHILE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015568	11	5248167	11	5226937	15568	30607	rs33958088	NC_000011.10:5226936:G:T
NM_000518.4(HBB):c.83C>A (p.Ala28Asp)	HBB|LOC106099062|LOC107133510	A28D	not provided	Pathogenic(Last reviewed: Nov 13, 2020)	criteria provided, single submitter	VCV000015386	11	5248169	11	5226939	15386	30425	rs33954632	NC_000011.10:5226938:G:T
NM_000518.4(HBB):c.83C>T (p.Ala28Val)	HBB|LOC106099062|LOC107133510	A28V	HEMOGLOBIN GRANGE-BLANCHE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015184	11	5248169	11	5226939	15184	30223	rs33954632	NC_000011.10:5226938:G:A
NM_000518.5(HBB):c.82G>T (p.Ala28Ser)	LOC107133510|LOC106099062|HBB	A28S	Hemoglobinopathy|not provided|beta Thalassemia|Hb SS disease	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015239	11	5248170	11	5226940	15239	30278	rs35424040	NC_000011.10:5226939:C:A
NM_000518.5(HBB):c.81G>C (p.Glu27Asp)	HBB|LOC106099062|LOC107133510	E27D	Hemoglobinopathy	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000599394	11	5248171	11	5226941	599394	590730	rs281864581	NC_000011.10:5226940:C:G
NM_000518.4(HBB):c.80A>C (p.Glu27Ala)	HBB|LOC106099062|LOC107133510	E27A	HEMOGLOBIN TRIPOLI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015614	11	5248172	11	5226942	15614	30653	rs33915112	NC_000011.10:5226941:T:G
NM_000518.4(HBB):c.80A>G (p.Glu27Gly)	HBB|LOC106099062|LOC107133510	E27G	Hb aubenas	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000015554	11	5248172	11	5226942	15554	30593	rs33915112	NC_000011.10:5226941:T:C
NM_000518.4(HBB):c.80A>T (p.Glu27Val)	HBB|LOC106099062|LOC107133510	E27V	HEMOGLOBIN HENRI MONDOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015194	11	5248172	11	5226942	15194	30233	rs33915112	NC_000011.10:5226941:T:A
NM_000518.5(HBB):c.79G>A (p.Glu27Lys)	HBB|LOC106099062|LOC107133510	E27K	Beta-thalassemia HBB/LCRB|beta Thalassemia|Hb SS disease|Methemoglobinemia, beta-globin type|alpha Thalassemia|Heinz body anemia|Erythrocytosis, familial, 6|Fetal hemoglobin quantitative trait locus 1|Dominant beta-thalassemia|Malaria, susceptibility to|Inborn genetic diseases|not specified|Hemoglobin E disease|not provided|beta Thalassemia|Hb SS disease|Anemia	Pathogenic(Last reviewed: Dec 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015161	11	5248173	11	5226943	15161	30200	rs33950507	NC_000011.10:5226942:C:T
NM_000518.5(HBB):c.77G>A (p.Gly26Asp)	HBB|LOC106099062|LOC107133510	G26D	HEMOGLOBIN J (AUCKLAND)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015212	11	5248175	11	5226945	15212	30251	rs35474880	NC_000011.10:5226944:C:T
NM_000518.4(HBB):c.76G>C (p.Gly26Arg)	HBB|LOC106099062|LOC107133510	G26R	HEMOGLOBIN G (TAIWAN-AMI)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015179	11	5248176	11	5226946	15179	30218	rs34404985	NC_000011.10:5226945:C:G
NM_000518.4(HBB):c.74G>T (p.Gly25Val)	HBB|LOC106099062|LOC107133510	G25V	HEMOGLOBIN SAVANNAH	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015344	11	5248178	11	5226948	15344	30383	rs33968721	NC_000011.10:5226947:C:A
NM_000518.4(HBB):c.74G>A (p.Gly25Asp)	HBB|LOC106099062|LOC107133510	G25D	HEMOGLOBIN MOSCVA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015275	11	5248178	11	5226948	15275	30314	rs33968721	NC_000011.10:5226947:C:T
NM_000518.5(HBB):c.73G>C (p.Gly25Arg)	HBB|LOC106099062|LOC107133510	G25R	HEMOGLOBIN RIVERDALE-BRONX	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015328	11	5248179	11	5226949	15328	30367	rs33972975	NC_000011.10:5226948:C:G
NM_000518.4(HBB):c.71T>C (p.Val24Ala)	HBB|LOC106099062|LOC107133510	V24A	HEMOGLOBIN ZOETERWOUDE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015618	11	5248181	11	5226951	15618	30657	rs33945546	NC_000011.10:5226950:A:G
NM_000518.4(HBB):c.71T>A (p.Val24Asp)	HBB|LOC106099062|LOC107133510	V24D	not provided	Uncertain significance(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000015358	11	5248181	11	5226951	15358	30397	rs33945546	NC_000011.10:5226950:A:T
NM_000518.4(HBB):c.71T>G (p.Val24Gly)	HBB|LOC106099062|LOC107133510	V24G	HEMOGLOBIN MIYASHIRO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015270	11	5248181	11	5226951	15270	30309	rs33945546	NC_000011.10:5226950:A:C
NM_000518.5(HBB):c.70G>C (p.Val24Leu)	HBB|LOC106099062|LOC107133510	V24L	not provided	Uncertain significance(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000496002	11	5248182	11	5226952	496002	487451	rs33929459	NC_000011.10:5226951:C:G
NM_000518.5(HBB):c.70G>A (p.Val24Ile)	HBB|LOC106099062|LOC107133510	V24I	Hemoglobinopathy	Pathogenic(Last reviewed: Jan 1, 2018)	no assertion criteria provided	VCV000478897	11	5248182	11	5226952	478897	38470	rs33929459	NC_000011.10:5226951:C:T
NM_000518.4(HBB):c.70G>T (p.Val24Phe)	HBB|LOC106099062|LOC107133510	V24F	Erythrocytosis, familial, 6|HEMOGLOBIN PALMERSTON NORTH	Pathogenic; other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015306	11	5248182	11	5226952	15306	30345	rs33929459	NC_000011.10:5226951:C:A
NM_000518.4(HBB):c.68A>G (p.Glu23Gly)	LOC107133510|HBB|LOC106099062	E23G	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 30, 2020)	criteria provided, conflicting interpretations	VCV000015178	11	5248184	11	5226954	15178	30217	rs33936254	NC_000011.10:5226953:T:C
NM_000518.4(HBB):c.68A>C (p.Glu23Ala)	HBB|LOC106099062|LOC107133510	E23A	not provided|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 10, 2021)	criteria provided, conflicting interpretations	VCV000015171	11	5248184	11	5226954	15171	30210	rs33936254	NC_000011.10:5226953:T:G
NM_000518.4(HBB):c.68A>T (p.Glu23Val)	LOC106099062|HBB|LOC107133510	E23V	not provided|Methemoglobinemia, beta-globin type|Malaria, susceptibility to|alpha Thalassemia|Heinz body anemia|Beta-thalassemia HBB/LCRB|Hereditary persistence of fetal hemoglobin|Erythrocytosis, familial, 6|Hb SS disease|Dominant beta-thalassemia	Uncertain significance(Last reviewed: Jul 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015149	11	5248184	11	5226954	15149	30188	rs33936254	NC_000011.10:5226953:T:A
NM_000518.4(HBB):c.67G>A (p.Glu23Lys)	LOC106099062|HBB|LOC107133510	E23K	not provided	Uncertain significance(Last reviewed: Oct 6, 2022)	criteria provided, single submitter	VCV000015162	11	5248185	11	5226955	15162	30201	rs33959855	NC_000011.10:5226954:C:T
NM_000518.4(HBB):c.67G>C (p.Glu23Gln)	HBB|LOC106099062|LOC107133510	E23Q	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2023)	criteria provided, conflicting interpretations	VCV000015151	11	5248185	11	5226955	15151	30190	rs33959855	NC_000011.10:5226954:C:G
NM_000518.5(HBB):c.65A>T (p.Asp22Val)	HBB|LOC106099062|LOC107133510	D22V	not provided	Uncertain significance(Last reviewed: Feb 12, 2021)	criteria provided, single submitter	VCV001330078	11	5248187	11	5226957	1330078	1320761		NC_000011.10:5226956:T:A
NM_000518.5(HBB):c.65A>G (p.Asp22Gly)	HBB|LOC106099062|LOC107133510	D22G	HEMOGLOBIN CONNECTICUT	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015142	11	5248187	11	5226957	15142	30181	rs33977536	NC_000011.10:5226956:T:C
NM_000518.4(HBB):c.64G>C (p.Asp22His)	HBB|LOC106099062|LOC107133510	D22H	HEMOGLOBIN KARLSKOGA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015520	11	5248188	11	5226958	15520	30559	rs33950093	NC_000011.10:5226957:C:G
NM_000518.4(HBB):c.64G>T (p.Asp22Tyr)	HBB|LOC106099062|LOC107133510	D22Y	not provided	Likely benign(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000015399	11	5248188	11	5226958	15399	30438	rs33950093	NC_000011.10:5226957:C:A
NM_000518.4(HBB):c.64G>A (p.Asp22Asn)	HBB|LOC106099062|LOC107133510	D22N	HEMOGLOBIN COCODY	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015140	11	5248188	11	5226958	15140	30179	rs33950093	NC_000011.10:5226957:C:T
NM_000518.5(HBB):c.62T>A (p.Val21Glu)	HBB|LOC106099062|LOC107133510	V21E	HEMOGLOBIN TROLLHAETTAN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015539	11	5248190	11	5226960	15539	30578	rs33918474	NC_000011.10:5226959:A:T
NM_000518.5(HBB):c.61G>A (p.Val21Met)	HBB|LOC106099062|LOC107133510	V21M	not provided|Beta-thalassemia HBB/LCRB|Hb SS disease|Hereditary persistence of fetal hemoglobin|Methemoglobinemia, beta-globin type|alpha Thalassemia|Heinz body anemia|Erythrocytosis, familial, 6|Dominant beta-thalassemia|Malaria, susceptibility to	Pathogenic(Last reviewed: Jan 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015300	11	5248191	11	5226961	15300	30339	rs35890959	NC_000011.10:5226960:C:T
NM_000518.5(HBB):c.60C>A (p.Asn20Lys)	HBB|LOC106099062|LOC107133510	N20K	not provided	Likely benign(Last reviewed: Apr 28, 2021)	criteria provided, single submitter	VCV000015153	11	5248192	11	5226962	15153	30192	rs63750840	NC_000011.10:5226961:G:T
NM_000518.5(HBB):c.59A>G (p.Asn20Ser)	LOC107133510|HBB|LOC106099062	N20S	not specified|not provided|beta Thalassemia	Pathogenic(Last reviewed: Aug 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015258	11	5248193	11	5226963	15258	30297	rs33972047	NC_000011.10:5226962:T:C
NM_000518.5(HBB):c.58A>G (p.Asn20Asp)	HBB|LOC106099062|LOC107133510	N20D	HEMOGLOBIN ALAMO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015093	11	5248194	11	5226964	15093	30132	rs34866629	NC_000011.10:5226963:T:C
NM_000518.5(HBB):c.56T>G (p.Val19Gly)	LOC107133510|HBB|LOC106099062	V19G	not provided|not specified	Uncertain significance(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000496000	11	5248196	11	5226966	496000	487512	rs35382661	NC_000011.10:5226965:A:C
NM_000518.5(HBB):c.55G>A (p.Val19Met)	HBB|LOC106099062|LOC107133510	V19M	HEMOGLOBIN BADEN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015517	11	5248197	11	5226967	15517	30556	rs35802118	NC_000011.10:5226966:C:T
NM_000518.5(HBB):c.54G>C (p.Lys18Asn)	HBB|LOC106099062|LOC107133510	K18N	HEMOGLOBIN J (AMIENS)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015210	11	5248198	11	5226968	15210	30249	rs36006214	NC_000011.10:5226967:C:G
NM_000518.5(HBB):c.52A>C (p.Lys18Gln)	HBB|LOC106099062|LOC107133510	K18Q	HEMOGLOBIN NIKOSIA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015500	11	5248200	11	5226970	15500	30539		NC_000011.10:5226969:T:G
NM_000518.5(HBB):c.52A>G (p.Lys18Glu)	HBB|LOC106099062|LOC107133510	K18E	HEMOGLOBIN NAGASAKI	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015282	11	5248200	11	5226970	15282	30321		NC_000011.10:5226969:T:C
NM_000518.5(HBB):c.50G>A (p.Gly17Asp)	HBB|LOC106099062|LOC107133510	G17D	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 21, 2022)	criteria provided, conflicting interpretations	VCV000015213	11	5248202	11	5226972	15213	30252	rs33962676	NC_000011.10:5226971:C:T
NM_000518.5(HBB):c.49G>C (p.Gly17Arg)	HBB|LOC106099062|LOC107133510	G17R	HEMOGLOBIN D (BUSHMAN)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015148	11	5248203	11	5226973	15148	30187	rs63751285	NC_000011.10:5226972:C:G
NM_000518.5(HBB):c.46T>G (p.Trp16Gly)	HBB|LOC106099062|LOC107133510	W16G	HEMOGLOBIN RANDWICK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015324	11	5248206	11	5226976	15324	30363	rs33946157	NC_000011.10:5226975:A:C
NM_000518.5(HBB):c.46T>A (p.Trp16Arg)	HBB|LOC106099062|LOC107133510	W16R	HEMOGLOBIN BELFAST	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015107	11	5248206	11	5226976	15107	30146	rs33946157	NC_000011.10:5226975:A:T
NM_000518.4(HBB):c.44T>G (p.Leu15Arg)	HBB|LOC106099062|LOC107133510	L15R	not provided	Uncertain significance(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000015355	11	5248208	11	5226978	15355	30394	rs33935445	NC_000011.10:5226977:A:C
NM_000518.4(HBB):c.44T>C (p.Leu15Pro)	HBB|LOC107133510|LOC106099062	L15P	not specified|not provided|Hb SS disease|Beta-thalassemia HBB/LCRB|Heinz body anemia|Hereditary persistence of fetal hemoglobin|Malaria, susceptibility to|alpha Thalassemia|Erythrocytosis, familial, 6|Methemoglobinemia, beta-globin type|Dominant beta-thalassemia	Uncertain significance(Last reviewed: Apr 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015341	11	5248208	11	5226978	15341	30380	rs33935445	NC_000011.10:5226977:A:G
NM_000518.5(HBB):c.41C>T (p.Ala14Val)	LOC106099062|LOC107133510|HBB	A14V	not specified|not provided	Uncertain significance(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619858	11	5248211	11	5226981	619858	611101	rs35203747	NC_000011.10:5226980:G:A
NM_000518.5(HBB):c.41C>A (p.Ala14Asp)	HBB|LOC106099062|LOC107133510	A14D	HEMOGLOBIN J (LENS)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015223	11	5248211	11	5226981	15223	30262	rs35203747	NC_000011.10:5226980:G:T
NM_000518.5(HBB):c.40G>A (p.Ala14Thr)	HBB|LOC106099062|LOC107133510	A14T	beta Thalassemia	Benign(Last reviewed: Dec 1, 2020)	no assertion criteria provided	VCV000995801	11	5248212	11	5226982	995801	983497	rs766266418	NC_000011.10:5226981:C:T
NM_000518.5(HBB):c.35T>A (p.Val12Asp)	HBB|LOC106099062|LOC107133510	V12D	HEMOGLOBIN WINDSOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015389	11	5248217	11	5226987	15389	30428	rs35140348	NC_000011.10:5226986:A:T
NM_000518.4(HBB):c.[34G>A;364G>A]	LOC106099062|HBB|LOC107133510|LOC110006319	V12I, E122K	HEMOGLOBIN O (TIBESTI)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446746	11|11	5248218	11|11	5226988	446746	30228|30331	rs33974228|rs33946267	NC_000011.10:5226987:C:T|NC_000011.10:5225677:C:T
NM_000518.4(HBB):c.34G>T (p.Val12Phe)	HBB|LOC106099062|LOC107133510	V12F	not provided	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000015535	11	5248218	11	5226988	15535	30574	rs33974228	NC_000011.10:5226987:C:A
NM_000518.4(HBB):c.34G>A (p.Val12Ile)	HBB|LOC106099062|LOC107133510	V12I	not specified|not provided|beta Thalassemia|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|Beta-thalassemia HBB/LCRB|Hb SS disease|Hereditary persistence of fetal hemoglobin|Methemoglobinemia, beta-globin type|alpha Thalassemia|Heinz body anemia|Erythrocytosis, familial, 6|Dominant beta-thalassemia|Malaria, susceptibility to	Uncertain significance(Last reviewed: Jul 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015189	11	5248218	11	5226988	15189	30228	rs33974228	NC_000011.10:5226987:C:T
NM_000518.4(HBB):c.32C>T (p.Ala11Val)	HBB|LOC106099062|LOC107133510	A11V	HEMOGLOBIN IRAQ-HALABJA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015571	11	5248220	11	5226990	15571	30610	rs33947457	NC_000011.10:5226989:G:A
NM_000518.4(HBB):c.32C>A (p.Ala11Asp)	HBB|LOC106099062|LOC107133510	A11D	HEMOGLOBIN ANKARA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015097	11	5248220	11	5226990	15097	30136	rs33947457	NC_000011.10:5226989:G:T
NM_000518.5(HBB):c.31G>A (p.Ala11Thr)	HBB|LOC106099062|LOC107133510	A11T	not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2022)	criteria provided, conflicting interpretations	VCV000439152	11	5248221	11	5226991	439152	432702	rs63750717	NC_000011.10:5226990:C:T
NM_000518.4(HBB):c.29C>A (p.Ser10Tyr)	HBB|LOC106099062|LOC107133510	S10Y	HEMOGLOBIN BREM-SUR-MER	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015619	11	5248223	11	5226993	15619	30658	rs33918131	NC_000011.10:5226992:G:T
NM_000518.4(HBB):c.29C>G (p.Ser10Cys)	LOC107133510|LOC106099062|HBB	S10C	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2021)	criteria provided, conflicting interpretations	VCV000015316	11	5248223	11	5226993	15316	30355	rs33918131	NC_000011.10:5226992:G:C
NM_000518.5(HBB):c.27G>C (p.Lys9Asn)	HBB|LOC106099062|LOC107133510	K9N	HEMOGLOBIN LIMASSOL	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015593	11	5248225	11	5226995	15593	30632	rs35198910	NC_000011.10:5226994:C:G
NM_000518.4(HBB):c.26A>G (p.Lys9Arg)	HBB|LOC106099062|LOC107133510	K9R	HEMOGLOBIN LUCKNOW	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015572	11	5248226	11	5226996	15572	30611	rs33932981	NC_000011.10:5226995:T:C
NM_000518.4(HBB):c.26A>T (p.Lys9Met)	HBB|LOC106099062|LOC107133510	K9M	HEMOGLOBIN NAKANO	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015548	11	5248226	11	5226996	15548	30587	rs33932981	NC_000011.10:5226995:T:A
NM_000518.4(HBB):c.26A>C (p.Lys9Thr)	HBB|LOC106099062|LOC107133510	K9T	HEMOGLOBIN RIO GRANDE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015327	11	5248226	11	5226996	15327	30366	rs33932981	NC_000011.10:5226995:T:G
NM_000518.4(HBB):c.25A>G (p.Lys9Glu)	HBB|LOC106099062|LOC107133510	K9E	not provided	Pathogenic(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV000015281	11	5248227	11	5226997	15281	30320	rs33926764	NC_000011.10:5226996:T:C
NM_000518.4(HBB):c.25A>C (p.Lys9Gln)	HBB|LOC106099062|LOC107133510	K9Q	HEMOGLOBIN J (LUHE)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015225	11	5248227	11	5226997	15225	30264	rs33926764	NC_000011.10:5226996:T:G
NM_000518.4(HBB):c.23A>G (p.Glu8Gly)	HBB|LOC106099062|LOC107133510	E8G	not specified|not provided	Likely benign(Last reviewed: Jan 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015176	11	5248229	11	5226999	15176	30215	rs34387455	NC_000011.10:5226998:T:C
NM_000518.5(HBB):c.22G>A (p.Glu8Lys)	HBB|LOC106099062|LOC107133510	E8K	not provided	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000015353	11	5248230	11	5227000	15353	30392	rs34948328	NC_000011.10:5226999:C:T
NM_000518.4(HBB):c.[205C>T;20A>T]	HBB|LOC106099062|LOC107133510	E7V, L69F	HEMOGLOBIN JAMAICA PLAIN	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446748	11|11	5248232	11|11	5227002	446748	30372|30652	rs334|rs33961459	NC_000011.10:5227001:T:A|NC_000011.10:5226686:G:A
NM_000518.4(HBB):c.[20A>T;428C>T]	LOC106099062|HBB|LOC107133510|LOC110006319	E7V, A143V	HEMOGLOBIN S (TRAVIS)	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000446738	11|11	5248232	11|11	5227002	446738	30372|38472	rs334|rs33921821	NC_000011.10:5227001:T:A|NC_000011.10:5225613:G:A
NM_000518.4(HBB):c.[20A>T;70G>A]	HBB|LOC106099062|LOC107133510	E7V, V24I	HEMOGLOBIN S (ANTILLES)	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000446735	11|11	5248232	11|11	5227002	446735	30372|38470	rs334|rs33929459	NC_000011.10:5227001:T:A|NC_000011.10:5226951:C:T
NM_000518.4(HBB):c.[176C>G;20A>T]	HBB|LOC106099062|LOC107133510	E7V, P59R	HEMOGLOBIN ZIGUINCHOR	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446731	11|11	5248232	11|11	5227002	446731	30372|30437	rs334|rs33991472	NC_000011.10:5227001:T:A|NC_000011.10:5226715:G:C
NM_000518.5(HBB):c.19_20delinsAT (p.Glu7Met)	HBB|LOC106099062|LOC107133510	E7M	beta Thalassemia	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036301	11	5248232 - 5248233	11	5227002 - 5227003	36301	44965	rs193922552	NC_000011.10:5227001:TC:AT
NM_000518.5(HBB):c.20A>T (p.Glu7Val)	HBB|LOC106099062|LOC107133510	E7V	HBB-Related Disorders|Beta-thalassemia HBB/LCRB|Sickle cell disease and related diseases|beta Thalassemia|Hb SS disease|Methemoglobinemia, beta-globin type|alpha Thalassemia|Heinz body anemia|Erythrocytosis, familial, 6|Fetal hemoglobin quantitative trait locus 1|Dominant beta-thalassemia|Malaria, susceptibility to|Inborn genetic diseases|not provided|Sickle cell-hemoglobin C disease|Hb SS disease|beta Thalassemia|See cases	Pathogenic(Last reviewed: Feb 17, 2023)	criteria provided, multiple submitters, no conflicts	VCV000015333	11	5248232	11	5227002	15333	30372	rs334	NC_000011.10:5227001:T:A
NM_000518.4(HBB):c.20A>C (p.Glu7Ala)	HBB|LOC106099062|LOC107133510	E7A	HEMOGLOBIN G (MAKASSAR)	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015175	11	5248232	11	5227002	15175	30214	rs334	NC_000011.10:5227001:T:G
NM_000518.4(HBB):c.[19G>A;286A>G]	HBB|LOC106099062|LOC107133510	E7K, K96E	HEMOGLOBIN ARLINGTON PARK	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000446729	11|11	5248233	11|11	5227003	446729	30165|30317	rs33930165|rs33914359	NC_000011.10:5227002:C:T|NC_000011.10:5226605:T:C
NM_000518.4(HBB):c.19G>C (p.Glu7Gln)	HBB|LOC106099062|LOC107133510	E7Q	HEMOGLOBIN MACHIDA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015243	11	5248233	11	5227003	15243	30282	rs33930165	NC_000011.10:5227002:C:G
NM_000518.4(HBB):c.19G>A (p.Glu7Lys)	HBB|LOC106099062|LOC107133510	E7K	Inborn genetic diseases|Beta-thalassemia HBB/LCRB|Hereditary persistence of fetal hemoglobin|beta Thalassemia|Hb SS disease|Methemoglobinemia, beta-globin type|alpha Thalassemia|Heinz body anemia|Erythrocytosis, familial, 6|Fetal hemoglobin quantitative trait locus 1|Dominant beta-thalassemia|Malaria, susceptibility to|not specified|not provided|Sickle cell-hemoglobin C disease|Hb SS disease|Heinz body anemia|beta Thalassemia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2023)	criteria provided, conflicting interpretations	VCV000015126	11	5248233	11	5227003	15126	30165	rs33930165	NC_000011.10:5227002:C:T
NM_000518.5(HBB):c.17C>G (p.Pro6Arg)	HBB|LOC106099062|LOC107133510	P6R	HEMOGLOBIN WARWICKSHIRE	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015387	11	5248235	11	5227005	15387	30426	rs34769005	NC_000011.10:5227004:G:C
NM_000518.5(HBB):c.16C>G (p.Pro6Ala)	HBB|LOC106099062|LOC107133510	P6A	not provided	Likely benign(Last reviewed: Dec 21, 2020)	criteria provided, single submitter	VCV001331036	11	5248236	11	5227006	1331036	1321711		NC_000011.10:5227005:G:C
NM_000518.5(HBB):c.10_16delinsTCTGACT (p.Leu4_Pro6delinsSerAspSer)	HBB|LOC106099062|LOC107133510		HEMOGLOBIN ANTALYA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV001327539	11	5248236 - 5248242	11	5227006 - 5227012	1327539	1318144		NC_000011.10:5227005:GAGTCAG:AGTCAGA
NM_000518.5(HBB):c.16C>T (p.Pro6Ser)	HBB|LOC106099062|LOC107133510	P6S	not specified|not provided	Uncertain significance(Last reviewed: Jun 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015540	11	5248236	11	5227006	15540	30579	rs33912272	NC_000011.10:5227005:G:A
NM_000518.5(HBB):c.11T>A (p.Leu4Gln)	HBB|LOC106099062|LOC107133510	L4Q	not specified	Uncertain significance(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000439132	11	5248241	11	5227011	439132	432703	rs63750720	NC_000011.10:5227010:A:T
NM_000518.5(HBB):c.10C>G (p.Leu4Val)	HBB|LOC106099062|LOC107133510	L4V	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV001330034	11	5248242	11	5227012	1330034	1320717		NC_000011.10:5227011:G:C
NM_000518.5(HBB):c.10C>A (p.Leu4Met)	HBB|LOC106099062|LOC107133510	L4M	not specified	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000632844	11	5248242	11	5227012	632844	621362	rs34126315	NC_000011.10:5227011:G:T
NM_000518.5(HBB):c.9T>A (p.His3Gln)	HBB|LOC106099062|LOC107133510	H3Q	HEMOGLOBIN OKAYAMA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015296	11	5248243	11	5227013	15296	30335	rs713040	NC_000011.10:5227012:A:T
NM_000518.4(HBB):c.8A>T (p.His3Leu)	HBB|LOC106099062|LOC107133510	H3L	HEMOGLOBIN GRAZ	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015518	11	5248244	11	5227014	15518	30557	rs33983205	NC_000011.10:5227013:T:A
NM_000518.5(HBB):c.8A>C (p.His3Pro)	HBB|LOC106099062|LOC107133510	H3P	not specified	Uncertain significance(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000015261	11	5248244	11	5227014	15261	30300	rs33983205	NC_000011.10:5227013:T:G
NM_000518.4(HBB):c.8A>G (p.His3Arg)	HBB|LOC106099062|LOC107133510	H3R	not provided	Likely benign(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000015156	11	5248244	11	5227014	15156	30195	rs33983205	NC_000011.10:5227013:T:C
NM_000518.5(HBB):c.7C>T (p.His3Tyr)	HBB|LOC106099062|LOC107133510	H3Y	HEMOGLOBIN FUKUOKA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015167	11	5248245	11	5227015	15167	30206	rs35906307	NC_000011.10:5227014:G:A
NM_000518.5(HBB):c.5T>G (p.Val2Gly)	HBB|LOC106099062|LOC107133510	V2G	HEMOGLOBIN WATFORD	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015587	11	5248247	11	5227017	15587	30626	rs33949930	NC_000011.10:5227016:A:C
NM_000518.5(HBB):c.5T>C (p.Val2Ala)	HBB|LOC106099062|LOC107133510	V2A	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2022)	criteria provided, conflicting interpretations	VCV000015323	11	5248247	11	5227017	15323	30362	rs33949930	NC_000011.10:5227016:A:G
NM_000518.5(HBB):c.5T>A (p.Val2Glu)	HBB|LOC106099062|LOC107133510	V2E	HEMOGLOBIN DOHA	other(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000015159	11	5248247	11	5227017	15159	30198	rs33949930	NC_000011.10:5227016:A:T
NM_000518.5(HBB):c.4G>T (p.Val2Leu)	HBB|LOC106099062|LOC107133510	V2L	Hb niigata	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000015558	11	5248248	11	5227018	15558	30597	rs33958358	NC_000011.10:5227017:C:A
NM_000518.5(HBB):c.4G>A (p.Val2Met)	HBB|LOC106099062|LOC107133510	V2M	not specified	Uncertain significance(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015359	11	5248248	11	5227018	15359	30398	rs33958358	NC_000011.10:5227017:C:T
NM_000518.5(HBB):c.3G>T (p.Met1Ile)	HBB|LOC106099062|LOC107133510	M1I	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869316	11	5248249	11	5227019	869316	857526	rs33930702	NC_000011.10:5227018:C:A
NM_000518.5(HBB):c.3G>C (p.Met1Ile)	HBB|LOC106099062|LOC107133510	M1I	beta Thalassemia	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000869315	11	5248249	11	5227019	869315	857527	rs33930702	NC_000011.10:5227018:C:G
NM_000518.5(HBB):c.3G>A (p.Met1Ile)	HBB|LOC106099062|LOC107133510	M1I	not specified|not provided|Dominant beta-thalassemia	Pathogenic(Last reviewed: Mar 21, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015519	11	5248249	11	5227019	15519	30558	rs33930702	NC_000011.10:5227018:C:T
NM_000518.5(HBB):c.2T>A (p.Met1Lys)	LOC106099062|HBB|LOC107133510	M1K	not provided|beta Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495986	11	5248250	11	5227020	495986	487518	rs33941849	NC_000011.10:5227019:A:T
NM_000518.5(HBB):c.2T>C (p.Met1Thr)	HBB|LOC106099062|LOC107133510	M1T	Beta-thalassemia HBB/LCRB|not provided|beta Thalassemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000036310	11	5248250	11	5227020	36310	44974	rs33941849	NC_000011.10:5227019:A:G
NM_000518.5(HBB):c.2T>G (p.Met1Arg)	HBB|LOC106099062|LOC107133510	M1R	not provided|beta Thalassemia|Hb SS disease	Pathogenic(Last reviewed: Oct 9, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015434	11	5248250	11	5227020	15434	30473	rs33941849	NC_000011.10:5227019:A:C
NM_000518.5(HBB):c.1A>C (p.Met1Leu)	LOC106099062|LOC107133510|HBB	M1L	not provided	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000869231	11	5248251	11	5227021	869231	857528	rs34563000	NC_000011.10:5227020:T:G
NM_000518.5(HBB):c.1A>G (p.Met1Val)	HBB|LOC106099062|LOC107133510	M1V	Hemoglobinopathy|not provided	Pathogenic(Last reviewed: Mar 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439140	11	5248251	11	5227021	439140	432704	rs34563000	NC_000011.10:5227020:T:C
